ciprofloxacin has been researched along with tobramycin in 328 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 29 (8.84) | 18.7374 |
| 1990's | 61 (18.60) | 18.2507 |
| 2000's | 113 (34.45) | 29.6817 |
| 2010's | 88 (26.83) | 24.3611 |
| 2020's | 37 (11.28) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, ML; Duffield, J; Hu, C; Hwang, SB; Ichikawa, Y; Liang, CH; Marby, KA; Rabuka, D; Romero, A; Sears, P; Sgarbi, PW; Shue, YK; Sucheck, SJ; Yao, S | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Duewelhenke, N; Eysel, P; Krut, O | 1 |
| Furuno, JP; Graffunder, E; Graves, J; Lodise, TP; Lomaestro, B; McGregor, JC; McNutt, LA; Miller, CD | 1 |
| Adams, J; de Oliveira Garcia, D; Doi, Y; Paterson, DL | 1 |
| El'Garch, F; Hocquet, D; Jeannot, K; Llanes-Barakat, C; Plésiat, P | 1 |
| Dumas, JL; Köhler, T; Reinhardt, A; Ricou, B; Rohner, P; van Delden, C; Wood, P | 1 |
| Costerton, JW; DeLancey Pulcini, E; Eldridge, GR; Garo, E; Goering, MG; Hamilton, MA; James, GA | 1 |
| Caniça, M; Ferreira, E; Leitão, J; Manageiro, V; Mendonça, N | 1 |
| Bonomo, RA; Endimiani, A; Hujer, AM; Hujer, KM; Luzzaro, F; Mantengoli, E; Migliavacca, R; Pagani, L; Rossolini, GM; Toniolo, A | 1 |
| Ariza, J; Dominguez, MA; Gudiol, F; Guzmán, A; Peña, C; Pujol, M; Suarez, C; Tubau, F | 1 |
| Adams, J; Paterson, DL; Peleg, AY | 1 |
| Avlami, A; Daikos, GL; Katsilambros, N; Kosmidis, C; Petrikkos, G; Psychogiou, M; Stefanou, I; Tassios, PT; Vasilakopoulou, A | 1 |
| Borrell, N; Maciá, MD; Moya, B; Oliver, A; Pérez, JL; Plasencia, V | 1 |
| Courvalin, P; Galimand, M; Périchon, B | 1 |
| Castanheira, M; Jones, RN; Mendes, RE; Sader, HS; Toleman, MA; Walsh, TR | 1 |
| Cheung, A; Götz, F; Herbert, S; Meehl, M | 1 |
| Beceiro, A; Bou, G; Canle, D; Fernández, A; Lasa, I; Latasa, C; Mallo, S; Molina, F; Pérez, A; Pérez, S; Poza, M; Tomás, Mdel M; Villanueva, R | 1 |
| Bajolet, O; Berthelot, P; Bingen, E; Couetdic, G; Favre, R; Grattard, F; Hocquet, D; Husson, MO; Jeannot, K; Mariani-Kurkdjian, P; Marty, N; Plésiat, P; Roussel-Delvallez, M | 1 |
| Liu, Y; Shi, W; Wang, M; Wu, S; Xu, X; Ye, X; Zhang, Y | 1 |
| Bouza, E; Cercenado, E; Coll, P; Gutiérrez, O; Juan, C; Navarro, F; Oliver, A; Pérez, JL | 1 |
| Andres, P; Centrón, D; Galas, M; Guerriero, L; Petroni, A; Quiroga, C; Quiroga, MP; Soler Bistué, AJ; Tokumoto, M; Tolmasky, ME; Vargas, LJ; Zorreguieta, A | 1 |
| Bertrand, X; Blanc, K; Hocquet, D; Monnet, DL; Muller, A; Plésiat, P; Talon, D | 1 |
| Adams-Haduch, JM; Doi, Y; Paterson, DL | 1 |
| Chen, T; Khalil, H; Riffon, R; Wang, R; Wang, Z | 1 |
| Arakawa, Y; Suzuki, S; Wachino, J; Yamane, K | 1 |
| Castanheira, M; Deshpande, LM; Martin, CA; Morita, K; Ribes, JA; Sader, HS | 1 |
| Bethel, CR; Bonomo, RA; Carias, LL; Endimiani, A; Fox, WR; Hall, GS; Hujer, AM; Hujer, KM; Hutton, RA; Jacobs, MR; Jenkins, SG; Paterson, DL; Perez, F; Rice, LB; Tenover, FC | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Attree, I; Elsen, S; Jeannot, K; Köhler, T; Plésiat, P; van Delden, C | 1 |
| Espedido, BA; Iredell, JR; Partridge, SR | 1 |
| Alba, V; Blasco, MD; Espinal, P; Fernández-Cuenca, F; Marti, S; Pascual, A; Ruiz, M; Sánchez-Céspedes, J; Vila, J | 1 |
| Badur, S; Cagatay, AA; Carrër, A; Eraksoy, H; Nordmann, P; Poirel, L | 1 |
| Albertí, S; Beceiro, A; Bou, G; Garau, M; Gutiérrez, O; Juan, C; Oliver, A; Pérez, JL | 1 |
| Cattoir, V; Nordmann, P; Poirel, L | 1 |
| Wang, H; Wu, X; Zhao, X | 1 |
| del Pozo, JL; Mandrekar, JN; Patel, R; Rouse, MS; Sampedro, MF; Steckelberg, JM | 1 |
| Esteban, J; Fernández-Martínez, AI; Fernández-Roblas, R; Gadea, I; García-Almeida, D; Martín-de-Hijas, NZ | 1 |
| Adams-Haduch, JM; Doi, Y; Harrison, LH; Muto, CA; Pasculle, AW; Paterson, DL; Potoski, BA; Sidjabat, HE | 1 |
| Berçot, B; Nordmann, P; Poirel, L | 1 |
| Bennett, JW; Herrera, ML; Jorgensen, JH; Lewis, JS; Wickes, BW | 1 |
| Andlovic, A; Jeverica, S; Karisik, E; Koren, S; Krizan-Hergouth, V; Livermore, DM; Mesko Meglic, K; Müller-Premru, M; Palepou, MF; Pike, R; Seme, K; Woodford, N | 1 |
| Baptista, BC; Correia, JD; da Fonseca, JD; Martínez-Martínez, L; Pomba, C | 1 |
| Bell, JM; Castanheira, M; Deshpande, LM; Jones, RN; Mendes, RE; Turnidge, JD | 1 |
| Bell, JM; Castanheira, M; Jones, RN; Mathai, D; Turnidge, JD | 1 |
| Juan, C; Maciá, MD; Mena, A; Mulet, X; Oliver, A; Pérez, JL | 1 |
| Duljasz, W; Gniadkowski, M; Jebelean, C; Sitter, S; Wojna, A | 1 |
| Attrée, I; Ducruix, A; El Garch, F; Llanes, C; Muller, C; Phan, G; Plésiat, P; Vettoretti, L | 1 |
| Choi, SH; Jeong, JY; Jun, JB; Kim, ES; Kim, MN; Kim, YS; Lee, SO; Woo, JH | 1 |
| Christiansen, LE; Ciofu, O; Høiby, N; Kirkby, N; Mandsberg, LF; Poulsen, HE | 1 |
| Hall, RM; Post, V | 1 |
| Campbell, L; Church, DL; Gregson, DB; Laupland, KB; Pitout, JD | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Brunner, LS; Haas, W; Lee, JC; Morris, TW; Pillar, CM; Zurenko, GE | 1 |
| Gaillard, JL; Jackson, M; McDonnell, G; Niederweis, M; Skovierová, H; Svetlíková, Z | 1 |
| Carattoli, A; Ellington, MJ; Karisik, E; Livermore, DM; Underwood, A; Woodford, N | 1 |
| Brasme, L; De Champs, C; Duval, V; Forte, D; Guillard, T; Madoux, J; Maiga, A; Maiga, I; Vernet-Garnier, V | 1 |
| Acosta, J; Chaves, F; Juan, C; Oliver, A; Otero, JR; Sanz, F; Viedma, E; Zamorano, L | 1 |
| Barrow, K; Kwon, DH | 1 |
| Albertí, S; Juan, C; Mulet, X; Oliver, A; Pérez, JL; Zamorano, L | 1 |
| Bulik, CC; Crandon, JL; Nicolau, DP | 1 |
| Aggen, JB; Armstrong, ES; Bonomo, RA; Choudhary, Y; Endimiani, A; Hujer, AM; Hujer, KM | 1 |
| Burns, JL; Dudley, MN; Griffith, DC; King, P; Lomovskaya, O | 1 |
| Albertí, S; Bengoechea, JA; Doménech-Sánchez, A; Llobet, E; Martínez-Martínez, L; Padilla, E | 1 |
| Courvalin, P; Coyne, S; Guigon, G; Périchon, B | 1 |
| Giske, CG; Hermansen, NO; Leegaard, TM; Lia, A; Rajendra, Y; Ranheim, TE; Rydberg, J; Samuelsen, O; Sundsfjord, A; Toleman, MA; Walder, M; Walsh, TR | 1 |
| Bulik, CC; Christensen, H; Nicolau, DP | 1 |
| Ge, Y; Juan, C; Oliver, A; Pérez, JL; Zamorano, L | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Dunman, PM; Hood, MI; Jacobs, AC; Sayood, K; Skaar, EP | 1 |
| Bunders, C; Huigens, RW; Melander, C; Reed, CS; Reyes, S; Rogers, SA; Steinhauer, AT | 1 |
| Alfa, M; Kibsey, P; Loo, V; McGeer, A; Nigrin, J; Peirano, G; Pienaar, C; Pitout, JD; Richardson, D; Toye, B | 1 |
| Beceiro, A; Bou, G; Doumith, M; Livermore, DM; Tomás, M; Turton, JF; Warner, M; Woodford, N | 1 |
| Chang, SC; Chen, YC; Hsia, KC; Li, SY; Liao, MH; Lin, YC; Sheng, WH | 1 |
| Chang, FY; Chen, TL; Fung, CP; Huang, LY; Lu, PL; Siu, LK | 1 |
| Barber, M; Eberly, LE; Feeney, LA; Miller, GH; Summers, A; Wortmann, G; Zapor, MJ | 1 |
| Abele-Horn, M; Claus, H; Elias, J; Engelhardt, K; Frosch, M; Joseph, B; Oesterlein, A; Schoen, C; Turnwald, D; Valenza, G | 1 |
| Cars, O; Löwdin, E; Melhus, A; Tängdén, T | 1 |
| Clark, M; Doolittle, J; Giddings, MC; Khatun, J; Ramkissoon, K; Secrest, A; Su, HC; Wolfgang, MC | 1 |
| Blázquez, J; Couce, A; Rodríguez-Rojas, A | 1 |
| Hamprecht, A; Higgins, PG; Schneiders, T; Seifert, H | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Maravić, A; Odžak, R; Skočibušić, M | 1 |
| Banerjee, A; Chakrapani, H; Lahiri, S; Malwal, SR; Pardeshi, KA; Rangarajan, R | 1 |
| Banerjee, S; Chhabra, M; Paira, P; Sinha, S | 1 |
| Fernando, DM; Gorityala, BK; Goswami, S; Guchhait, G; Kumar, A; Schweizer, F; Zhanel, GG | 1 |
| Barros R S, V; Das, I; Décout, JL; Désiré, J; El Khoury, M; Mingeot-Leclercq, MP; Sautrey, G; Zimmermann, L | 1 |
| Brozovic, A; Dowson, CG; Gazvoda, M; Košmrlj, J; Lloyd, A; Osmak, M; Proud, C; Roper, DI; Vajs, J | 1 |
| Ashenden, S; Bender, A; Cokol, M; Karakoc, I; Kuru, N; Mason, DJ; Meral, S; Stott, I; Weinstein, ZB | 1 |
| Domalaon, R; Gorityala, BK; Goswami, S; Idowu, T; Lyu, Y; Schweizer, F; Shan, A; Yang, X; Zhanel, GG | 1 |
| Bojkovic, J; Dean, CR; Dobler, M; Dzink-Fox, J; Glick, M; Hamann, LG; Kerrigan, J; Lanieri, L; Lenoir, F; Lilly, MD; Liu, E; Lu, Y; McKenney, D; Nunez, J; Osborne, C; Parker, DT; Patnaik, A; Peng, Y; Piizzi, G; Ranjitkar, S; Sprague, ER; Tommasi, R; Wang, B; Wang, H; Wattanasin, S; Xie, L; Yang, X; Yu, D | 1 |
| Briée, F; Décout, JL; Kempf, J; Mingeot-Leclercq, MP; Swain, J; Zimmermann, L | 1 |
| Bera, S; Mondal, D | 1 |
| Ammeter, D; Idowu, T; Rossong, H; Schweizer, F; Zhanel, GG | 1 |
| Jiang, K; Lin, F; Wu, H; Xiao, J; Xiao, Z; Yan, X; Yu, J; Yue, Y; Zhao, M; Zhou, X | 1 |
| Alam, S; Ammeter, D; Brizuela, M; Idowu, T; Jackson, G; Schweizer, F | 1 |
| Chang, YQ; Chen, WM; Hou, JS; Lin, J; Liu, J; Miao, ZY; Peng, LJ; Sun, PH; Zhang, XY | 1 |
| Lohan, S; Mohammed, EHM; Parang, K; Tiwari, RK | 1 |
| Allison, DG; Matthews, MJ | 1 |
| Dyke, JW; Hay, MB; Kumar, A; Maier, GA | 1 |
| Brown, MR; Duguid, IG; Evans, E; Gilbert, P | 1 |
| Bangsborg, J; Frimodt-Møller, N; Gutschik, E; Westh, H | 1 |
| Andersen, BM; Bergan, T; Brubakk, O; Bruun, JN; Døskeland, B; Hellum, KB; Hopen, G; Kalager, T; Rahm, V; von der Lippe, E | 1 |
| Giamarellou, H; Xirouchaki, E | 1 |
| Adams, K; Calhoun, J; Cierny, G; Couch, L; Mader, JT | 1 |
| Goodwin, SD; Heyd, A; Nix, DE; Wilton, JH | 1 |
| Adelman, MH; Nix, DE; Schentag, JJ | 1 |
| Jurado, R; Kindelan, JM; López-Villarejo, P; No-Louis, E | 1 |
| Forman, K; Hill, JM; Hobden, JA; O'Callaghan, RJ; Reidy, JJ | 1 |
| Leibowitz, HM | 1 |
| Ansorg, R; Müller, KD; Wiora, J | 1 |
| Bale, MJ; Doebbeling, BN; Pfaller, MA; Wenzel, RP | 1 |
| Hill, JM; Hobden, JA; Insler, MS; O'Callaghan, RJ; Reidy, JJ | 1 |
| Grise, G; Le Boete, I; Lecomte, F; Lemeland, JF; Thauvin-Eliopoulos, C | 1 |
| Haas, CE; Nix, DE; Schentag, JJ | 1 |
| Gordon, JJ; Kauffman, CA | 1 |
| Grimwood, K; Rabin, HR; To, M; Woods, DE | 1 |
| Gadebusch, HH; Gilfillan, EC; Pelak, BA; Valiant, ME | 1 |
| Daschner, F; Kropec, A | 1 |
| LeVatte, MA; Sokol, PA | 1 |
| Bransby-Zachary, MA; Hawkey, PM; Millar, MR; Myles Gibson, R; Tompkins, DS | 1 |
| Lerk, CF; Stoutenbeek, CP; van Saene, HK; van Saene, JJ | 1 |
| Gratz, JC; Maserati, R; Scheld, WM; Strunk, RW | 1 |
| Chalkley, LJ; Koornhof, HJ | 1 |
| Grohe, K; Metzger, KG; Schacht, P; Zeiler, HJ | 1 |
| Gruninger, R; Guay, DR; Gustilo, RB; Peterson, PK; Tsukayama, DT; Wicklund, B | 1 |
| Rubio, TT; Shapiro, C | 1 |
| Chambers, HF; Hackbarth, CJ; Sande, MA; Shibl, AM; Stella, F | 1 |
| Andriole, VT; Johnson, M; Miniter, P | 1 |
| Fuursted, K | 1 |
| Fuursted, K; Gerner-Smidt, P | 1 |
| Hoogeterp, JJ; Mattie, H; Terporten, P | 2 |
| Meyran, M; Thabaut, A | 1 |
| Norden, CW; Shinners, E | 1 |
| Overbeek, BP; Rozenberg-Arska, M; Verhoef, J | 1 |
| Mellinghoff, D; Shah, PM; Stille, W | 1 |
| Bosso, JA; Walker, KB | 1 |
| Holden, P; Nix, DE; Rescott, DL; Schentag, JJ | 1 |
| Hirschhorn, L; Neu, HC | 1 |
| Black, PG; Bosso, JA; Matsen, JM | 1 |
| Rubio, TT | 1 |
| Davidson, S; Nakatomi, M; Neu, HC; Ores, C; Scully, BE | 1 |
| Pohlod, DJ; Saravolatz, LD | 1 |
| Pennington, JE; Schiff, JB; Small, GJ | 1 |
| Allison, DG; McKenney, D; Trueman, PA; Willcock, L | 1 |
| Erlendsdóttir, H; Gottfredsson, M; Gudmundsson, A; Gudmundsson, S | 1 |
| Callegan, MC; Engel, LS; Hill, JM; Hobden, JA; O'Callaghan, RJ; Reidy, JJ | 1 |
| Ciofu, O; Giwercman, B; Høiby, N; Pedersen, SS | 1 |
| Braga, B; Brazzoli, A; Depetri, G; Gazzotti, RM; Losio, R; Mileti, M; Usberti, M; Zucca, F | 1 |
| Eftimimiadou, A; Kaliengidou, M; Kartali, S; Panagoutsos, S; Papazoglou, D; Pasadakis, P; Thodis, E; Vargemezis, V | 1 |
| Callegan, MC; Engel, LS; Hill, JM; O'Callaghan, RJ | 2 |
| Gilbert, C; Hussein, A; Meisenberg, B; Perfect, J; Peters, WP; Ross, M; Vredenburgh, J | 1 |
| Cohen, KL; Lauffenburger, MD | 1 |
| Bion, JF; Crosby, HA; Elliott, TS; Penn, CW | 1 |
| Maskin, SL | 1 |
| Beagley, MJ; Kelman, GJ; Roland, GC | 1 |
| Bosso, JA; Burgess, DS; Manduru, M; White, RL | 1 |
| Hostacka, A | 2 |
| Dalla Costa, T; Derendorf, H | 1 |
| Adenis, JP; Badrinath, SS; Caldwell, DR; Eiferman, RA; Hyndiuk, RA; Katz, HR; Klauss, V; Reddy, MK; Rosenwasser, GO; Santos, CI | 1 |
| Flynn, CM; Johnson, DM; Jones, RN | 1 |
| Church, DA; Echols, RM; Haverstock, DC; Kanga, JF; Kuhn, RJ; Painter, BG; Perroncel, RY; Rubio, TT; Spohn, WA; Stevens, JC; Thurberg, BE | 1 |
| Martinez-Martinez, L; Pascual, A; Perea, EJ; Rodriguez, G; Suárez, AI | 1 |
| Cormio, L; La Forgia, P; Ruutu, M; Siitonen, A; Talja, M; Törmälä, P | 1 |
| Hybenová, D; Majtán, V | 1 |
| Iaconis, JP; Nadler, HL; Pitkin, DH; Sheikh, W | 1 |
| Benzer, H; Berger, J; Javorsky, F; Lejeune, P; Lingnau, W; Mutz, N | 1 |
| Durmaz, B; Durmaz, R; Günal, S; Hepsen, IF; Marol, S; Oram, O | 1 |
| Hampel, BJ; Nousia-Arvanitakis, S; Richard, DA; Schaad, UB; Sollich, V; Sommerauer, B | 1 |
| Cormio, L; La Forgia, D; La Forgia, P; Ruutu, M; Siitonen, A | 1 |
| Kong, CH; Lee, SW; Li, RC | 1 |
| Gross, RD; Hoffman, RO; Lindsay, RN | 1 |
| Muszynski, MJ; Rajyaguru, JM | 1 |
| Allison, DG; McKenney, D | 1 |
| Ben-David, J; Brodsky, A; Fradis, M; Larboni, J; Podoshin, L; Srugo, I | 1 |
| Hostacká, A; Majtán, V | 1 |
| Ben-David, J; Brodzki, A; Fradis, M; Larboni, J; Podoshin, L; Srugo, I | 1 |
| Cross, AS; Marre, R; Rukavina, T; Trautmann, M; Zick, R | 1 |
| Chaudhry, NA; Davis, J; Miller, D; Rosenfeld, PJ; Tabandeh, H | 1 |
| Beck, R; Drewelow, B; Guthoff, R; Hehl, EM; Kundt, G; Luthardt, K | 1 |
| Caron, F | 1 |
| Bingen, E; Bonacorsi, S; Fitoussi, F; Lhopital, S | 1 |
| Bergmann, JS; Boulet, B; Brown, BA; Fahle, GA; Plaunt, M; Wallace, RJ; Wanger, A; Witebsky, FG; Woods, GL | 1 |
| Po, AL; Scott, EM; Tariq, VN; Wu, YL | 1 |
| Beck, R; Drewelow, B; Guthoff, R; Hehl, EM; Luthard, K | 1 |
| Bent, JP; Hebert, RL; King, GE; Vick, ML | 1 |
| Alexandrakis, G; Alfonso, EC; Miller, D | 1 |
| Hartnick, CJ; Myer, CM; Shott, S; Willging, JP | 1 |
| Maniatis, AN; Polyzou, A; Pournaras, S; Slavakis, A; Sofianou, D; Tsakris, A | 1 |
| Baron, D; Bonnieux, J; Bourrier, P; Le Conte, P; Lebrin, P; Merit, JB; Potel, G; Simon, N | 1 |
| Hsu, S; Kass, JS; Krishnan, RS; Lewis, AT | 1 |
| Hein, H; Oesser, S; Schulze, C; Seifert, J | 1 |
| Amorena, B; García-Alvarez, F; Gracia, E; Laclériga, A; Leiva, J; Monzón, M; Oteiza, C | 1 |
| Cappuccinelli, P; Carta, F; Delogu, G; Pinna, A; Sechi, LA; Usai, D; Zanetti, S | 1 |
| Barnhill, MA; Hendrix, DV; Ward, DA | 1 |
| Assael, BM; Candusso, M; Faraguna, D; Marchetti, F | 1 |
| Griese, M; Müller, I; Reinhardt, D | 1 |
| Cushing, DA; Donowitz, GR; Harman, CP; Haverstock, DC; Herrington, DA; Hurd, DD; Kowalsky, SF; Lazarus, HM; Peacock, JE; Reed, MD; Sinclair, JW; Wade, JC | 1 |
| IJzerman, WL; Neef, C; van Gils, SA | 1 |
| Bugnicourt, A; Franklin, MJ; Roe, F; Stewart, PS; Walters, MC | 1 |
| Bodey, GP; Raad, II; Rolston, KV | 1 |
| Fishman, N; Linkin, DR | 1 |
| Donnenfeld, ED; O'Brien, TP; Perry, HD; Solomon, R; Speaker, MG; Wittpenn, J | 1 |
| Daines, BS; Sandoval, HP; Solomon, KD; Steed, LL; Vroman, DT | 1 |
| Sloan, B; Watson, A | 1 |
| Pitt, TL; Sparrow, M; Stefanidou, M; Warner, M | 1 |
| Jones, RN; Rhomberg, PR | 1 |
| Contag, PR; Francis, KP; Kadurugamuwa, JL; Kimura, R; Purchio, T; Sin, LV; Yu, J | 1 |
| Wu, XD; Yang, YH; Yao, K; Zhang, Z | 1 |
| Kim, JK; Park, SN; Suh, H | 1 |
| Ariano, RE; Harding, GK; Iacovides, H; Zelenitsky, SA | 1 |
| Fish, DN; Jung, R; MacLaren, R; Obritsch, MD | 1 |
| Crombleholme, T; Keswani, S; Parvadia, JK; Potsic, WP; Sobol, SE | 1 |
| Alvarez, A; Baquero, F; Cantón, R; Cobos, N; de Gracia, J; García-Quetglas, E; Gartner, S; Honorato, J; Oliver, A; Salcedo, A | 1 |
| Aktas, E; Durmaz, R; Kalcioglu, MT; Ozturan, O | 1 |
| Borrell, N; Gómez, C; Maciá, MD; Oliver, A; Pérez, JL; Segura, M | 1 |
| Sharma, N; Singhvi, A; Sinha, R; Tandon, R | 1 |
| Alvarez, FG; Amorena, B; García-Alvarez, F; García-Alvarez, I; Grasa, JM; Laclériga, A; Monzón, M; Navarro-Zorraquino, M | 1 |
| Bilton, D; Gotfried, M; Henig, N; Morrissey, B | 1 |
| Arlandis Guzmán, S; Bonillo García, MA; Bosquet Sanz, M; Gimeno Argente, V; Jiménez Cruz, JF; Trassierra Villa, M | 1 |
| Gordon, YJ; Kowalski, RP; Mah, FS; Romanowski, EG; Yates, KA | 1 |
| Adams, CS; Antoci, V; Hickok, NJ; Parvizi, J; Shapiro, IM | 1 |
| Bouchard, CS; Bu, P; Carey, R; Riske, PS; Zaya, NE | 1 |
| Alecsandru, D; Garcia, A; Gestoso, I; Lobo, J; Martinez, A; Romero, A; Yagüe, MR | 1 |
| An, MM; Cai, Y; Fang, Y; Liang, BB; Wang, R | 1 |
| Andrei, I; Babu Rao Ambati, V; Haas, GJ; Katta, S; Leonida, M; Natarajan, P | 1 |
| Mah, TF; Zhang, L | 1 |
| Banerjee, AR; Biswas, MC; Kundu, PK; Mandal, R; Mondal, A; Sasmal, NK | 1 |
| Malcolm, KC; Nick, JA; Parks, QM; Poch, KR; Vasil, ML; Young, RL | 1 |
| Naranjo-Tackman, R; Stangogiannis-Druya, C; Stangogiannis-Druya, E; Vanzzini, V; Villar-Kurí, J | 1 |
| Bertram, C; Elborn, JS; Hodson, M | 1 |
| Boni, V; Braccini, G; Braggion, C; Campana, S; Festini, F; Galici, V; Neri, AS; Taccetti, G; Trevisan, F; Zavataro, L | 1 |
| Emerson, J; Gibson, RL; Kronmal, RA; Mayer-Hamblett, N; Ramsey, BW; Retsch-Bogart, G; Rosenfeld, M; Treggiari, MM; Williams, J | 1 |
| An, MM; Cai, Y; Liang, BB; Wang, R; Yu, XH | 1 |
| Langton Hewer, SC; Smyth, AR | 3 |
| Benus, RF; Bernards, SA; Blok, HE; Bonten, MJ; de Jongh, BM; de Smet, AM; Frénay, IH; Jansz, AR; Kaan, JA; Kluytmans, JA; Leverstein-van Hall, MA; Mascini, EM; Oostdijk, EA; Pauw, W; Sturm, PD; Thieme Groen, ES; Thijsen, SF; van Asselt, GJ | 1 |
| Dundar, D; Otkun, M | 1 |
| Gordon, YJ; Kowalski, RP; Mah, FS; Romanowski, EG; Shanks, RM | 1 |
| Baquero, F; Cantón, R; del Campo, R; García-Castillo, M; Morosini, MI; Turrientes, MC; Zamora, J | 1 |
| Kostenko, V; Lyczak, J; Martinuzzi, RJ; Turner, K | 1 |
| Armero, C; Gobernado, M; González, F; López-Quílez, A; Perpiñán, H; Sahuquillo-Arce, JM; Selva, M; Vanaclocha, H | 1 |
| Cho, E; Davidson, AG; Lillquist, YP | 1 |
| Abdiche, G; Batellier, L; Borsali, E; Chaumeil, C; Gleize, D; Goldschmdt, P; Laroche, L; Le Bouter, A; Legrand, P | 1 |
| Li, Y; Liu, MT; Sheng, MY; Zhang, Y | 1 |
| Burns, JL; Gibson, RL; Khan, U; Kronmal, RA; Mayer-Hamblett, N; Ramsey, BW; Retsch-Bogart, G; Rosenfeld, M; Treggiari, MM | 1 |
| Burns, JL; Chatfield, BA; Froh, DK; Gibson, RL; Hiatt, P; Khan, U; Kronmal, R; Kulich, M; Mayer-Hamblett, N; Orenstein, D; Ramsey, BW; Retsch-Bogart, G; Rosenfeld, M; Spencer, T; Treggiari, MM; Williams, J | 1 |
| Cohen, MB; Saiman, L | 1 |
| Narten, M; Rosin, N; Schobert, M; Tielen, P | 1 |
| Anan, N; Ito, A; Nakamura, R; Toba, S; Tsuji, M | 1 |
| Housman, ST; Nicolau, DP; Sutherland, C | 1 |
| Bozkurt-Guzel, C; Gerceker, AA; Savage, PB | 1 |
| Franklin, MJ; McInnerney, K; Perez-Osorio, AC; Pitts, B; Richards, LA; Stewart, PS; Williamson, KS | 1 |
| Bianchini, E; Buzzetti, R; Campana, S; Cariani, L; Costantini, D; Taccetti, G; Trevisan, F; Zavataro, L | 1 |
| Hewer, SL | 1 |
| Boulanger, L; De Boeck, K; Proesmans, M; Verhaegen, J; Vermeulen, F | 1 |
| Bahar, AA; Pan, J; Ren, D; Syed, H | 1 |
| Bertram, R; Klumpp, S; Lechner, S; Patra, P | 1 |
| Caceres, S; Caverly, L; Fratelli, C; Kim, SH; Malcolm, K; Moskowitz, S; Nichols, DP; Nick, JA; Poch, KR; Saavedra, M; Solomon, G; Taylor-Cousar, J | 1 |
| Chopp, DL; Harrison, JJ; Packman, AI; Parsek, MR; Penterman, J; Quach, TP; Singh, PK; Song, JL; Tseng, BS; Zhang, W | 1 |
| Eberl, T; Jung, JS; Kostrzewa, M; Lange, C; Schubert, S; Sparbier, K; Wieser, A | 1 |
| Baek, JY; Cho, SY; Chung, DR; Kang, CI; Kim, J; Kim, SH; Ko, KS; Peck, KR; Song, JH | 1 |
| McDonald, EM; McGhee, CN; Patel, DV; Ram, FS | 1 |
| Buroni, S; Coenye, T; Matthijs, N; Pasca, MR; Riccardi, G; Scoffone, VC; Spadaro, F; Van Acker, H | 1 |
| Buyck, JM; Tulkens, PM; Van Bambeke, F | 1 |
| Boegli, L; Folsom, JP; Franklin, MJ; James, GA; Stewart, PS; Williamson, KS | 1 |
| Blaskovich, MA; Butler, MS; Cooper, MA; Elliott, AG; Huang, JX; Kavanagh, A; Montgomery, AB; Pelingon, R; Ramu, S | 1 |
| Kotsimbos, T; Langan, KM; Peleg, AY | 1 |
| Gholipourmalekabadi, M; Hashemi, A; Mozafari, M; Rostami, A; Sameni, M; Zamani, F | 1 |
| Baziard, G; El Hage, S; Furiga, A; Lajoie, B; Roques, C | 1 |
| Kostrzewa, M; Schubert, S; Sparbier, K | 1 |
| Bergen, PJ; Hirsch, EB; Kirkpatrick, CM; Landersdorfer, CB; McIntosh, MP; Peleg, AY; Walsh, CC | 1 |
| Brul, S; Feng, Y; Jonker, MJ; Moustakas, I; Ter Kuile, BH | 1 |
| Banerjee, R; Boyce, TG; Cunningham, SA; Hasassri, ME; Jeraldo, PR; Kaye, KS; Norgan, AP; Patel, R; Pogue, JM; Weissman, SJ | 1 |
| Acke, M; Coenye, T; Cools, F; Cos, P; Gielis, J; Van Acker, H | 1 |
| Kim, SY; Lee, HS; Park, MH; Roh, EY | 1 |
| Auerbach, AD; Dvorak, CC; Levy, ER; Sabnis, AJ; Wattier, RL | 1 |
| Gu, L; Li, R; Liu, Y; Qu, J; Wang, P; Wei, M; Yang, C | 1 |
| Goodlet, KJ; Nailor, MD; Nicolau, DP | 1 |
| Nuxoll, E; Ricker, EB | 1 |
| Alfonso, EC; Gibbons, A; Miller, D; OʼBrien, TP; Palioura, S; Spierer, O | 1 |
| Armstrong, R; Felix, LM; Grundy, S; Harrison, H; Lynes, D; Milan, SJ; Spencer, S | 1 |
| Ali, AA; Ghadam, P; Gharavi, S; Tavafi, H | 1 |
| Britton, WJ; Chan, HK; Chang, RYK; Kutter, E; Lin, Y; Morales, S | 1 |
| Asbell, PA; DeCory, HH | 1 |
| Claude, F; Hafen, GM; Rochat, I | 1 |
| Grimwood, K; Harun, SN; Hennig, S; Holford, NHG; Wainwright, CE | 1 |
| Awad, R; Couet, W; Marchand, S; Tewes, F; Torres, BGS | 1 |
| Bell, SC; Brockway, B; Lamont, IL; Patrick, WM; Ramsay, KA; Reid, DW; Wardell, SJT; Winstanley, C | 1 |
| Elgaher, WAM; Haupenthal, J; Hirsch, AKH; Lababidi, N; Ofosu Kissi, E; Rades, T; Schneider, M; Schwarz, BC; Sigal, V | 1 |
| Blimkie, T; Coleman, SR; Falsafi, R; Hancock, REW | 1 |
| El-Wafa, WMA; Ibrahim, YM | 1 |
| Cheng, Z; Daboor, SM; Rohde, JR | 1 |
| Chaud, MV; da Conceição Amaro Martins, V; Daza, JHU; Lopes Baratella da Cunha Camargo, I; Maria de Guzzi Plepis, A; Righetto, GM | 1 |
| Archetti, M; Baumgartner, M; Kümmerli, R; Mignot, I; Rezzoagli, C | 1 |
| Habeeb Rasool, K; Hammood Hussein, N; Mahamed Taha, B | 1 |
| de Souza Carvalho-Wodarz, C; Lababidi, N; Lehr, CM; Montefusco-Pereira, CV; Schneider, M | 1 |
| Biavasco, F; Carotti, E; Cedraro, N; Citterio, B; La Teana, A; Mangiaterra, G; Vaiasicca, S | 1 |
| Ahn, J; Dawan, J; Kim, JC | 1 |
| Bai, F; Chen, S; Cheng, Z; Fan, Z; Jin, Y; Li, S; Liang, Y; Liu, H; Pan, X; Pletzer, D; Ren, H; Wang, P; Wu, W; Xu, C; Xu, J; Zhang, J; Zhang, Y; Zhou, J; Zhu, G | 1 |
| Christophersen, L; Høiby, N; Jensen, PØ; Laulund, AS; Lerche, CJ; Moser, C; Schwartz, FA; Woetmann, A | 1 |
| Bosch, T; Dijk, KV; Lankelma, JM; Schouls, LM; Sieswerda, E | 1 |
| Cooksley, CM; Feizi, S; Nepal, R; Psaltis, AJ; Vreugde, S; Wormald, PJ | 1 |
| Buyuksahin, HN; Dogru, D; Emiralioglu, N; Guzelkas, I; Hazirolan, G; Kiper, N; Özçelik, U; Ozsezen, B; Şener, B; Sunman, B; Tural, DA; Yalcin, E | 1 |
| Daneman, N; Elligsen, M; Katz, K; Lam, PW; Lo, J; MacFadden, D; Teitelbaum, D; Vermeiren, C | 1 |
| Ardebili, A; Bagheri, H; Goharrizi, MASB; Hjimohammadi, A; Izanloo, A; Jamali, A; Shahri, FN | 1 |
| Abulaila, A; Aktas, Z; Cantón, R; Díez-Aguilar, M; Erdem, F; Kayacan, C; Morosini, MI; Oksuz, L; Oncul, O | 1 |
| Abbasi, SA; Ali, S; Andleeb, S; Awan, UA; Imdad, K; Mughal, TA; Nasreen, S; Raja, SA | 1 |
| Gu, H; Tong, K; Wei, J; Zhou, S | 1 |
| Adomako, LAB; Alaverdyan, S; Appiah, F; Appiah-Thompson, BL; Ashubwe-Jalemba, J; Baanam, MY; Hope, PKF; Kamau, EM; Kwarteng Amaning, E; Lynen, L; Mensah, B; Peprah Boaitey, K | 1 |
| Aldogan, EH; Hacioglu, M; Yilmaz, FN | 1 |
| Friman, VP; Law, JP; Wood, AJ | 1 |
| Berry, N; Byrne, DP; Fernig, DG; Foulkes, DM; Haneef, AS; Kaye, SB; McLean, K; Rustidge, S; Sloniecka, M; Winstanley, C | 1 |
| Hernando-Amado, S; Laborda, P; López-Causapé, C; Martínez, JL; Oliver, A; Sanz-García, F | 1 |
| Caljon, B; Crombé, F; De Geyter, D; Demuyser, T; Janssen, T; Muyldermans, A; Piérard, D; Seyler, L; Vanstokstraeten, R; Wybo, I | 1 |
| Khan, M; Ma, K; Wan, I; Willcox, MD | 1 |
| Hernando-Amado, S; Laborda, P; Martínez, JL | 1 |
| Arslan, N; Esen, N; Özkarataş, MH; Özkütük, AA | 1 |
| Alisoltani, A; Atassi, G; Hauser, AR; Medernach, R; Murphy, KR; Murphy-Belcaster, M; Nozick, S; Ozer, EA; Rhodes, NJ; Scheetz, M | 1 |
| Langton Hewer, SC; Rowbotham, NJ; Smith, S; Smyth, AR; Yule, A | 1 |
| Beigverdi, R; Emaneini, M; Halimi, S; Jabalameli, F; Siroosi, M | 1 |
| Cruz Spano, L; Dos Santos, KV; Ferreira da Silva, A; Gastaldi Guerrieri, C; Souza Dos Santos, AL; Teixeira Gonçalves, M | 1 |
| Bjarnsholt, T; Christophersen, L; Eldrup, N; Moser, C; Qvortrup, K; Schwartz, F; Sunnerhagen, T; Vogt, K | 1 |
13 review(s) available for ciprofloxacin and tobramycin
| Article | Year |
|---|---|
Insights of synthetic analogues of anti-leprosy agents.
Topics: Humans; Leprostatic Agents; Leprosy; Structure-Activity Relationship | 2019 |
[Current role of aminoglycosides in the treatment of acute pyelonephritis].
Topics: Acute Disease; Administration, Oral; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Cefadroxil; Cefotaxime; Cephalosporins; Ciprofloxacin; Clinical Trials as Topic; Drug Therapy, Combination; Female; Gentamicins; Humans; Infusions, Intravenous; Inpatients; Male; Norfloxacin; Pyelonephritis; Recurrence; Time Factors; Tobramycin; Urinary Tract Infections | 1998 |
Infectious keratitis after photorefractive keratectomy.
Topics: Adult; Ciprofloxacin; Corneal Ulcer; Cross Infection; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Humans; Lasers, Excimer; Methicillin Resistance; Photorefractive Keratectomy; Polymyxins; Retrospective Studies; Risk Factors; Staphylococcal Infections; Streptococcal Infections; Tobramycin; Trimethoprim; Visual Acuity | 2003 |
Rapid diagnosis and treatment of mycobacterial keratitis after laser in situ keratomileusis.
Topics: Amikacin; Bacteriological Techniques; Ciprofloxacin; Clarithromycin; Corneal Ulcer; Diagnostic Techniques, Ophthalmological; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Humans; Indicators and Reagents; Keratomileusis, Laser In Situ; Middle Aged; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Myopia; Postoperative Complications; Staining and Labeling; Tobramycin | 2003 |
Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients.
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Bronchopneumonia; Cefepime; Ceftazidime; Cephalosporins; Ciprofloxacin; Colistin; Cystic Fibrosis; Drug Therapy, Combination; Humans; Inhalation; Injections, Intravenous; Lung Diseases; Pneumonia, Bacterial; Practice Guidelines as Topic; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin | 2005 |
Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis.
Topics: Administration, Inhalation; Administration, Oral; Adult; Anti-Bacterial Agents; Child; Ciprofloxacin; Cystic Fibrosis; Humans; Pseudomonas aeruginosa; Pseudomonas Infections; Randomized Controlled Trials as Topic; Tobramycin | 2009 |
Inhaled antibiotics in cystic fibrosis: what's new?
Topics: Administration, Inhalation; Adolescent; Amikacin; Anti-Bacterial Agents; Aztreonam; Child; Child, Preschool; Ciprofloxacin; Clinical Trials, Phase III as Topic; Cystic Fibrosis; Female; Follow-Up Studies; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Incidence; Infant; Male; Randomized Controlled Trials as Topic; Risk Assessment; Severity of Illness Index; Survival Rate; Tobramycin; Treatment Outcome | 2012 |
Topical antibiotics for the management of bacterial keratitis: an evidence-based review of high quality randomised controlled trials.
Topics: Administration, Topical; Anti-Bacterial Agents; Ciprofloxacin; Corneal Ulcer; Eye Infections, Bacterial; Fluoroquinolones; Humans; Ophthalmic Solutions; Randomized Controlled Trials as Topic; Tobramycin | 2014 |
Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis.
Topics: Administration, Inhalation; Administration, Oral; Adult; Anti-Bacterial Agents; Child; Ciprofloxacin; Colistin; Cystic Fibrosis; Humans; Pseudomonas aeruginosa; Pseudomonas Infections; Randomized Controlled Trials as Topic; Tobramycin | 2014 |
Managing Pseudomonas aeruginosa respiratory infections in cystic fibrosis.
Topics: Administration, Inhalation; Administration, Oral; Anti-Bacterial Agents; Chronic Disease; Ciprofloxacin; Cystic Fibrosis; Drug Resistance, Fungal; Humans; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections; Tobramycin | 2015 |
Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis.
Topics: Administration, Inhalation; Administration, Oral; Adult; Anti-Bacterial Agents; Child; Ciprofloxacin; Colistin; Cystic Fibrosis; Humans; Pseudomonas aeruginosa; Pseudomonas Infections; Randomized Controlled Trials as Topic; Respiratory System; Tobramycin | 2017 |
Dual antibiotics for bronchiectasis.
Topics: Adult; Anti-Bacterial Agents; Bronchiectasis; Ciprofloxacin; Gentamicins; Humans; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Randomized Controlled Trials as Topic; Tobramycin | 2018 |
Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis.
Topics: Anti-Bacterial Agents; Azithromycin; Ceftazidime; Child; Child, Preschool; Ciprofloxacin; Colistin; Cystic Fibrosis; Humans; Infant; Monobactams; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin | 2023 |
26 trial(s) available for ciprofloxacin and tobramycin
| Article | Year |
|---|---|
Ciprofloxacin versus a tobramycin/cefuroxime combination in the treatment of serious systemic infections: a prospective, randomized and controlled study of efficacy and safety.
Topics: Adult; Aged; Bacteremia; Cefuroxime; Ciprofloxacin; Drug Therapy, Combination; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Respiratory Tract Infections; Tobramycin; Treatment Outcome; Urinary Tract Infections | 1992 |
Antibacterial effectiveness of ciprofloxacin 0.3% ophthalmic solution in the treatment of bacterial conjunctivitis.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Ciprofloxacin; Conjunctivitis; Humans; Ophthalmic Solutions; Prospective Studies; Tobramycin | 1991 |
Ciprofloxacin versus tobramycin plus azlocillin in pulmonary exacerbations in adult patients with cystic fibrosis.
Topics: Adult; Anti-Bacterial Agents; Azlocillin; Bacterial Infections; Ciprofloxacin; Clinical Trials as Topic; Cystic Fibrosis; Drug Therapy, Combination; Humans; Lung Diseases; Random Allocation; Therapeutic Equivalency; Tobramycin | 1987 |
Ciprofloxacin: comparative data in cystic fibrosis.
Topics: Adolescent; Adult; Azlocillin; Ciprofloxacin; Clinical Trials as Topic; Cystic Fibrosis; Drug Therapy, Combination; Female; Humans; Lung Diseases; Male; Penicillin Resistance; Pseudomonas Infections; Tobramycin | 1987 |
Ciprofloxacin therapy in cystic fibrosis.
Topics: Adolescent; Adult; Azlocillin; Child; Ciprofloxacin; Clinical Trials as Topic; Cystic Fibrosis; Drug Therapy, Combination; Female; Humans; Lung Diseases; Male; Pseudomonas Infections; Tobramycin | 1987 |
Sequential prophylactic oral and empiric once-daily parenteral antibiotics for neutropenia and fever after high-dose chemotherapy and autologous bone marrow support.
Topics: Administration, Oral; Adult; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Bone Marrow Purging; Bone Marrow Transplantation; Breast Neoplasms; Ciprofloxacin; Drug Administration Schedule; Drug Therapy, Combination; Female; Fever; Humans; Injections, Intravenous; Middle Aged; Neutropenia; Rifampin; Stem Cell Transplantation; Tobramycin; Vancomycin | 1994 |
Comparison of ciprofloxacin ophthalmic solution 0.3% to fortified tobramycin-cefazolin in treating bacterial corneal ulcers. Ciprofloxacin Bacterial Keratitis Study Group.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Cefazolin; Cephalosporins; Child; Ciprofloxacin; Cornea; Corneal Ulcer; Double-Blind Method; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Humans; Male; Middle Aged; Ophthalmic Solutions; Prospective Studies; Tobramycin | 1996 |
Sequential ciprofloxacin therapy in pediatric cystic fibrosis: comparative study vs. ceftazidime/tobramycin in the treatment of acute pulmonary exacerbations. The Cystic Fibrosis Study Group.
Topics: Acute Disease; Adolescent; Anti-Infective Agents; Arthralgia; Ceftazidime; Child; Child, Preschool; Ciprofloxacin; Cystic Fibrosis; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Logistic Models; Male; Pneumonia, Bacterial; Prospective Studies; Pseudomonas Infections; Tobramycin; Treatment Outcome | 1997 |
Selective intestinal decontamination in multiple trauma patients: prospective, controlled trial.
Topics: Adult; Amphotericin B; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Translocation; Ciprofloxacin; Colistin; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Intestines; Male; Multiple Trauma; Pneumonia; Prospective Studies; Respiration, Artificial; Tobramycin | 1997 |
Aqueous humor penetration of topically applied ciprofloxacin, ofloxacin and tobramycin.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Aqueous Humor; Biological Assay; Ciprofloxacin; Female; Humans; Male; Middle Aged; Ofloxacin; Tobramycin | 1997 |
Oral ciprofloxacin vs. intravenous ceftazidime plus tobramycin in pediatric cystic fibrosis patients: comparison of antipseudomonas efficacy and assessment of safety with ultrasonography and magnetic resonance imaging. Cystic Fibrosis Study Group.
Topics: Administration, Oral; Adolescent; Cartilage; Ceftazidime; Child; Child, Preschool; Ciprofloxacin; Cystic Fibrosis; Drug Therapy, Combination; Female; Humans; Magnetic Resonance Imaging; Male; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin; Ultrasonography | 1997 |
A comparison of ciprofloxacin and tobramycin in bacterial conjunctivitis in children.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Child; Ciprofloxacin; Conjunctivitis; Double-Blind Method; Female; Humans; Infant, Newborn; Male; Ophthalmic Solutions; Tobramycin | 1997 |
Chronic otitis media treated topically with ciprofloxacin or tobramycin.
Topics: Administration, Topical; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Chronic Disease; Ciprofloxacin; Double-Blind Method; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Otitis Media; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin; Treatment Outcome | 1997 |
[Local treatment of purulent chronic otitis media with ciprofloxacin].
Topics: Administration, Topical; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Chronic Disease; Ciprofloxacin; Female; Humans; Male; Middle Aged; Otitis Media, Suppurative; Pharmaceutical Solutions; Pseudomonas Infections; Tobramycin | 1998 |
Improved penetration of aminoglycosides and fluorozuinolones into the aqueous humour of patients by means of Acuvue contact lenses.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Aqueous Humor; Ciprofloxacin; Contact Lenses, Hydrophilic; Drug Delivery Systems; Eye Infections; Female; Gentamicins; Humans; Kanamycin; Male; Middle Aged; Ofloxacin; Ophthalmic Solutions; Staphylococcus epidermidis; Tobramycin | 1999 |
[Acute pyelonephritis. Randomized multicenter double-blind study comparing ciprofloxacin with combined ciprofloxacin and tobramycin].
Topics: Acute Disease; Adult; Aged; Ciprofloxacin; Double-Blind Method; Drug Therapy, Combination; Escherichia coli Infections; Female; Humans; Male; Middle Aged; Pyelonephritis; Tobramycin | 2001 |
Eradication of initial Pseudomonas aeruginosa colonization in patients with cystic fibrosis.
Topics: Administration, Inhalation; Administration, Oral; Adolescent; Adult; Case-Control Studies; Ceftazidime; Child; Child, Preschool; Ciprofloxacin; Colistin; Cystic Fibrosis; Drug Therapy, Combination; Humans; Infant; Injections, Intravenous; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin; Treatment Outcome | 2002 |
Ciprofloxacin plus piperacillin compared with tobramycin plus piperacillin as empirical therapy in febrile neutropenic patients. A randomized, double-blind trial.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Bone Marrow Transplantation; Ciprofloxacin; Double-Blind Method; Drug Therapy, Combination; Female; Fever; Humans; Leukemia; Lymphoma; Male; Middle Aged; Neutropenia; Opportunistic Infections; Penicillins; Piperacillin; Tobramycin | 2002 |
[Aqueous humor penetration of topically applied ofloxacin, ciprofloxacin and tobramycin].
Topics: Administration, Topical; Aged; Aqueous Humor; Ciprofloxacin; Endophthalmitis; Female; Humans; Male; Middle Aged; Ofloxacin; Tobramycin | 2003 |
Addition of inhaled tobramycin to ciprofloxacin for acute exacerbations of Pseudomonas aeruginosa infection in adult bronchiectasis.
Topics: Administration, Inhalation; Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bronchiectasis; Ciprofloxacin; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Lung; Male; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin; Treatment Outcome; United Kingdom; United States | 2006 |
[Comparative study between tobramicin and tobramicin plus ciprofloxacin in transrectal prostate biopsy prophylaxis].
Topics: Aged; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotic Prophylaxis; Biopsy, Needle; Ciprofloxacin; Humans; Male; Prospective Studies; Prostate; Tobramycin | 2006 |
Early anti-pseudomonal acquisition in young patients with cystic fibrosis: rationale and design of the EPIC clinical trial and observational study'.
Topics: Age Factors; Anti-Bacterial Agents; Child; Child, Preschool; Ciprofloxacin; Cohort Studies; Cystic Fibrosis; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Infant; Longitudinal Studies; Male; Pseudomonas aeruginosa; Pseudomonas Infections; Risk Factors; Tobramycin; Treatment Outcome | 2009 |
Initial Pseudomonas aeruginosa treatment failure is associated with exacerbations in cystic fibrosis.
Topics: Anti-Bacterial Agents; Child; Child, Preschool; Ciprofloxacin; Cystic Fibrosis; Female; Humans; Male; Pseudomonas aeruginosa; Pseudomonas Infections; Recurrence; Risk; Tobramycin; Treatment Failure | 2012 |
Comparative efficacy and safety of 4 randomized regimens to treat early Pseudomonas aeruginosa infection in children with cystic fibrosis.
Topics: Administration, Inhalation; Administration, Oral; Anti-Bacterial Agents; Anti-Infective Agents; Child; Child, Preschool; Ciprofloxacin; Cystic Fibrosis; Female; Humans; Infant; Male; Placebos; Proportional Hazards Models; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin; Treatment Outcome; United States | 2011 |
Early antibiotic treatment for Pseudomonas aeruginosa eradication in patients with cystic fibrosis: a randomised multicentre study comparing two different protocols.
Topics: Administration, Inhalation; Administration, Oral; Anti-Bacterial Agents; Chi-Square Distribution; Child; Child, Preschool; Ciprofloxacin; Colistin; Cystic Fibrosis; Drug Therapy, Combination; Female; Forced Expiratory Volume; Humans; Infant; Male; Pseudomonas aeruginosa; Pseudomonas Infections; Stenotrophomonas maltophilia; Tobramycin; Treatment Outcome | 2012 |
Comparison of two treatment regimens for eradication of Pseudomonas aeruginosa infection in children with cystic fibrosis.
Topics: Administration, Inhalation; Adolescent; Anti-Bacterial Agents; Anti-Infective Agents; Child; Child, Preschool; Ciprofloxacin; Colistin; Cystic Fibrosis; Drug Therapy, Combination; Female; Forced Expiratory Volume; Humans; Infant; Male; Prospective Studies; Pseudomonas Infections; Sputum; Tobramycin; Treatment Outcome | 2013 |
289 other study(ies) available for ciprofloxacin and tobramycin
| Article | Year |
|---|---|
Structure-activity relationships of bivalent aminoglycosides and evaluation of their microbiological activities.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Drug Evaluation, Preclinical; Female; Humans; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Structure-Activity Relationship | 2005 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Influence on mitochondria and cytotoxicity of different antibiotics administered in high concentrations on primary human osteoblasts and cell lines.
Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Antimycin A; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cells, Cultured; Chloramphenicol; Clindamycin; Dose-Response Relationship, Drug; Fluoroquinolones; Glycolysis; HeLa Cells; Humans; Lactic Acid; Linezolid; Macrolides; Mitochondria; Osteoblasts; Oxazolidinones; Rotenone; Tetracyclines; Time Factors | 2007 |
Clinical prediction tool to identify patients with Pseudomonas aeruginosa respiratory tract infections at greatest risk for multidrug resistance.
Topics: Adult; Anti-Bacterial Agents; Case-Control Studies; Drug Resistance, Multiple, Bacterial; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Predictive Value of Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections; Retrospective Studies; Risk; Risk Factors | 2007 |
Coproduction of novel 16S rRNA methylase RmtD and metallo-beta-lactamase SPM-1 in a panresistant Pseudomonas aeruginosa isolate from Brazil.
Topics: Amino Acid Sequence; Aminoglycosides; beta-Lactamases; Brazil; Carbapenems; Cloning, Molecular; Drug Resistance, Multiple, Bacterial; Methyltransferases; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Pseudomonas aeruginosa; Pseudomonas Infections | 2007 |
Cumulative effects of several nonenzymatic mechanisms on the resistance of Pseudomonas aeruginosa to aminoglycosides.
Topics: Aminoglycosides; Anti-Bacterial Agents; Biological Evolution; DNA Transposable Elements; DNA, Bacterial; Drug Resistance, Bacterial; Gene Silencing; Genes, Bacterial; Microbial Sensitivity Tests; Mutagenesis, Insertional; Mutation; Pseudomonas aeruginosa; Reverse Transcriptase Polymerase Chain Reaction | 2007 |
Development and persistence of antimicrobial resistance in Pseudomonas aeruginosa: a longitudinal observation in mechanically ventilated patients.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Drug Resistance, Bacterial; Humans; Longitudinal Studies; Pneumonia, Ventilator-Associated; Polymerase Chain Reaction; Pseudomonas aeruginosa; Pseudomonas Infections | 2007 |
Asiatic acid and corosolic acid enhance the susceptibility of Pseudomonas aeruginosa biofilms to tobramycin.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Biofilms; Ciprofloxacin; Drug Synergism; Microbial Sensitivity Tests; Pentacyclic Triterpenes; Pseudomonas aeruginosa; Tobramycin; Triterpenes | 2007 |
Spread of extended-spectrum beta-lactamase CTX-M-producing escherichia coli clinical isolates in community and nosocomial environments in Portugal.
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests; Middle Aged; Portugal | 2007 |
Spread in an Italian hospital of a clonal Acinetobacter baumannii strain producing the TEM-92 extended-spectrum beta-lactamase.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cross Infection; Humans; Italy; Microbial Sensitivity Tests | 2007 |
Effects of carbapenem exposure on the risk for digestive tract carriage of intensive care unit-endemic carbapenem-resistant Pseudomonas aeruginosa strains in critically ill patients.
Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Carrier State; Critical Illness; Endemic Diseases; Female; Gastrointestinal Tract; Humans; Imipenem; Incidence; Intensive Care Units; Male; Middle Aged; Pharynx; Pseudomonas aeruginosa; Pseudomonas Infections; Rectum; Risk Factors | 2007 |
Tigecycline Efflux as a Mechanism for Nonsusceptibility in Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacterial Proteins; Drug Resistance, Bacterial; Ethidium; Gene Expression Regulation, Bacterial; Humans; Membrane Transport Proteins; Microbial Sensitivity Tests; Minocycline; Molecular Sequence Data; Sequence Analysis, DNA; Tigecycline | 2007 |
Enterobacteriaceae bloodstream infections: presence of integrons, risk factors, and outcome.
Topics: Bacteremia; Community-Acquired Infections; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterobacteriaceae Infections; Gene Transfer, Horizontal; Humans; Infectious Disease Transmission, Professional-to-Patient; Integrons; Microbial Sensitivity Tests; Nucleic Acid Amplification Techniques; Polymerase Chain Reaction; Prospective Studies; Risk Factors; Sequence Analysis, DNA; Treatment Outcome | 2007 |
Influence of high mutation rates on the mechanisms and dynamics of in vitro and in vivo resistance development to single or combined antipseudomonal agents.
Topics: Animals; Anti-Bacterial Agents; Ceftazidime; Ciprofloxacin; Disease Models, Animal; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Female; Humans; In Vitro Techniques; Lung; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Mutation; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin | 2007 |
Transferable resistance to aminoglycosides by methylation of G1405 in 16S rRNA and to hydrophilic fluoroquinolones by QepA-mediated efflux in Escherichia coli.
Topics: Amino Acid Motifs; Amino Acid Sequence; Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Conjugation, Genetic; Conserved Sequence; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Escherichia coli; Escherichia coli Proteins; Fluoroquinolones; Genes, rRNA; Methylation; Methyltransferases; Microbial Sensitivity Tests; Molecular Sequence Data; Norfloxacin; Plasmids; Sequence Analysis, DNA; Sequence Homology, Amino Acid | 2007 |
Characterization of an integron carrying blaIMP-1 and a new aminoglycoside resistance gene, aac(6')-31, and its dissemination among genetically unrelated clinical isolates in a Brazilian hospital.
Topics: Acinetobacter; Amino Acid Sequence; Aminoglycosides; Anti-Bacterial Agents; Base Sequence; Brazil; Codon, Terminator; Cross Infection; Drug Resistance, Multiple, Bacterial; Gene Transfer, Horizontal; Genes, Bacterial; Hospitals; Humans; Integrons; Microbial Sensitivity Tests; Molecular Sequence Data; Open Reading Frames; Plasmids; Pseudomonas putida; Transcription, Genetic | 2007 |
Interaction of the GraRS two-component system with the VraFG ABC transporter to support vancomycin-intermediate resistance in Staphylococcus aureus.
Topics: Anti-Bacterial Agents; ATP-Binding Cassette Transporters; Bacterial Proteins; Gene Expression Regulation, Bacterial; Humans; Microbial Sensitivity Tests; Polymyxin B; Signal Transduction; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2007 |
Cloning, nucleotide sequencing, and analysis of the AcrAB-TolC efflux pump of Enterobacter cloacae and determination of its involvement in antibiotic resistance in a clinical isolate.
Topics: Bacterial Proteins; Base Sequence; beta-Lactamases; Carrier Proteins; Cloning, Molecular; DNA, Bacterial; Drug Resistance, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Genes, MDR; Genetic Vectors; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Porins | 2007 |
Pseudomonas aeruginosa may accumulate drug resistance mechanisms without losing its ability to cause bloodstream infections.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteremia; beta-Lactams; DNA, Bacterial; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Fluoroquinolones; Genotype; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Reverse Transcriptase Polymerase Chain Reaction | 2007 |
Prevalence and expression of the plasmid-mediated quinolone resistance determinant qnrA1.
Topics: Anti-Infective Agents; Base Sequence; Ciprofloxacin; DNA, Bacterial; Drug Resistance, Bacterial; Enterobacter cloacae; Enterobacteriaceae; Gene Expression Regulation, Bacterial; Genes, Bacterial; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Polymerase Chain Reaction; Promoter Regions, Genetic; Quinolones; Reverse Transcriptase Polymerase Chain Reaction; Sequence Analysis, DNA; Sequence Homology, Nucleic Acid | 2007 |
Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Spanish hospitals.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Chromosomes, Bacterial; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Integrons; Molecular Epidemiology; Molecular Sequence Data; Mutation; Plasmids; Polymerase Chain Reaction; Porins; Pseudomonas aeruginosa; Sequence Analysis, DNA; Sequence Homology, Amino Acid; Spain | 2007 |
Complex class 1 integrons with diverse variable regions, including aac(6')-Ib-cr, and a novel allele, qnrB10, associated with ISCR1 in clinical enterobacterial isolates from Argentina.
Topics: Alleles; Amino Acid Sequence; Argentina; Bacterial Proteins; Base Sequence; beta-Lactamases; Cross Infection; DNA Transposable Elements; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Integrons; Microbial Sensitivity Tests; Molecular Sequence Data; Polymerase Chain Reaction; Sequence Analysis, DNA; Sequence Homology, Nucleic Acid | 2007 |
Relationship between antibiotic use and incidence of MexXY-OprM overproducers among clinical isolates of Pseudomonas aeruginosa.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Bacterial Proteins; Cefepime; Cephalosporins; Culture Media; Drug Resistance, Multiple; Fluoroquinolones; France; Hospitals, University; Humans; Incidence; Membrane Transport Proteins; Microbial Sensitivity Tests; Mutation; Pseudomonas aeruginosa; Pseudomonas Infections | 2008 |
Escherichia coli isolate coproducing 16S rRNA Methylase and CTX-M-type extended-spectrum beta-lactamase isolated from an outpatient in the United States.
Topics: Ambulatory Care; Aminoglycosides; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Humans; Methyltransferases; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; RNA, Ribosomal, 16S; Sequence Analysis, DNA; United States | 2008 |
Synergy between polyethylenimine and different families of antibiotics against a resistant clinical isolate of Pseudomonas aeruginosa.
Topics: Aminoglycosides; Anti-Bacterial Agents; Carbenicillin; Ceftazidime; Ciprofloxacin; Drug Resistance, Bacterial; Drug Synergism; Humans; Microbial Sensitivity Tests; Novobiocin; Ofloxacin; Piperacillin; Polyethyleneimine; Pseudomonas aeruginosa; Pseudomonas Infections; Rifampin; Ticarcillin; Tobramycin | 2008 |
Plasmid-mediated qepA gene among Escherichia coli clinical isolates from Japan.
Topics: Anti-Bacterial Agents; Conjugation, Genetic; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Fluoroquinolones; Hospitals; Humans; Japan; Microbial Sensitivity Tests; Plasmids; Prevalence | 2008 |
IMP-15-producing Pseudomonas aeruginosa strain isolated in a U.S. medical center: a recent arrival from Mexico.
Topics: Adult; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Hospitals; Humans; Imipenem; Kentucky; Male; Mexico; Pseudomonas aeruginosa; United States | 2008 |
Presence of plasmid-mediated quinolone resistance in Klebsiella pneumoniae isolates possessing blaKPC in the United States.
Topics: Aged; Bacterial Proteins; Base Sequence; beta-Lactamases; DNA Primers; DNA, Bacterial; Drug Resistance, Bacterial; Genes, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Molecular Epidemiology; Plasmids; Quinolones; United States | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Resistance and virulence of Pseudomonas aeruginosa clinical strains overproducing the MexCD-OprJ efflux pump.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; Ciprofloxacin; DNA Primers; DNA-Binding Proteins; DNA, Bacterial; Drug Resistance, Bacterial; Female; Genes, Bacterial; Humans; Male; Membrane Proteins; Membrane Transport Proteins; Middle Aged; Molecular Sequence Data; Mutation; Pseudomonas aeruginosa; Pseudomonas Infections; Transcription Factors; Virulence | 2008 |
bla(IMP-4) in different genetic contexts in Enterobacteriaceae isolates from Australia.
Topics: Australia; Bacterial Proteins; beta-Lactamases; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Molecular Sequence Data; Polymerase Chain Reaction; Sequence Analysis, DNA | 2008 |
Characterization of the carbapenem-hydrolyzing oxacillinase oxa-58 in an Acinetobacter genospecies 3 clinical isolate.
Topics: Acinetobacter; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; beta-Lactamases; Carbapenems; Humans; Imipenem; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Sequence Analysis, DNA | 2008 |
Spread of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in Istanbul, Turkey.
Topics: Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Models, Genetic; Turkey | 2008 |
Characterization of the new metallo-beta-lactamase VIM-13 and its integron-borne gene from a Pseudomonas aeruginosa clinical isolate in Spain.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; beta-Lactam Resistance; beta-Lactamases; Cloning, Molecular; DNA Primers; DNA, Bacterial; Genes, Bacterial; Genetic Variation; Humans; Imipenem; Integrons; Kinetics; Meropenem; Molecular Sequence Data; Phylogeny; Pseudomonas aeruginosa; Pseudomonas Infections; Recombinant Proteins; Sequence Homology, Amino Acid; Spain; Thienamycins | 2008 |
Plasmid-mediated quinolone resistance pump QepA2 in an Escherichia coli isolate from France.
Topics: Aged; Base Sequence; DNA Primers; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Fluoroquinolones; France; Genes, Bacterial; Humans; Models, Genetic; Molecular Sequence Data; Plasmids | 2008 |
Antimicrobial studies with the Pseudomonas aeruginosa two-allele library require caution.
Topics: Alleles; DNA Transposable Elements; DNA, Bacterial; Drug Resistance, Bacterial; Gene Library; Genes, Bacterial; Humans; Microbial Sensitivity Tests; Mutation; Pseudomonas aeruginosa; Pyocyanine | 2008 |
Effect of electrical current on the activities of antimicrobial agents against Pseudomonas aeruginosa, Staphylococcus aureus, and Staphylococcus epidermidis biofilms.
Topics: Anti-Infective Agents; Biofilms; Bioreactors; Electricity; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Staphylococcus aureus; Staphylococcus epidermidis | 2009 |
In vitro activities of tigecycline and 10 other antimicrobials against nonpigmented rapidly growing mycobacteria.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Minocycline; Mycobacterium; Mycobacterium Infections; Pigmentation; Species Specificity; Tigecycline | 2008 |
Genetic basis of multidrug resistance in Acinetobacter baumannii clinical isolates at a tertiary medical center in Pennsylvania.
Topics: Academic Medical Centers; Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Base Sequence; beta-Lactamases; Cross Infection; DNA Primers; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Genes, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Epidemiology; Pennsylvania; Polymerase Chain Reaction | 2008 |
Plasmid-mediated 16S rRNA methylases among extended-spectrum beta-lactamase-producing Enterobacteriaceae isolates.
Topics: Anti-Bacterial Agents; beta-Lactamases; Conjugation, Genetic; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Escherichia coli; Humans; Methyltransferases; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Sequence Analysis, DNA; Transformation, Bacterial | 2008 |
KPC-2-producing Enterobacter cloacae and pseudomonas putida coinfection in a liver transplant recipient.
Topics: Anti-Bacterial Agents; beta-Lactamases; Enterobacter cloacae; Female; Humans; Liver Transplantation; Microbial Sensitivity Tests; Middle Aged; Pseudomonas putida; RNA, Ribosomal, 16S | 2009 |
Nationwide survey of CTX-M-type extended-spectrum beta-lactamases among Klebsiella pneumoniae isolates in Slovenian hospitals.
Topics: Anti-Bacterial Agents; beta-Lactamases; Electrophoresis, Gel, Pulsed-Field; Genes, Bacterial; Hospitals; Klebsiella pneumoniae; Microbial Sensitivity Tests; Slovenia | 2009 |
Detection of the pandemic O25-ST131 human virulent Escherichia coli CTX-M-15-producing clone harboring the qnrB2 and aac(6')-Ib-cr genes in a dog.
Topics: Animals; Anti-Bacterial Agents; Dogs; Drug Resistance, Bacterial; Escherichia coli; Genes, Bacterial; Humans; Plasmids; Virulence | 2009 |
Codetection of blaOXA-23-like gene (blaOXA-133) and blaOXA-58 in Acinetobacter radioresistens: report from the SENTRY antimicrobial surveillance program.
Topics: Acinetobacter; Anti-Bacterial Agents; beta-Lactamases; Drug Resistance, Bacterial; Molecular Sequence Data; Plasmids; Population Surveillance; Reverse Transcriptase Polymerase Chain Reaction; Transcription, Genetic | 2009 |
Carbapenem resistance among Pseudomonas aeruginosa strains from India: evidence for nationwide endemicity of multiple metallo-beta-lactamase clones (VIM-2, -5, -6, and -11 and the newly characterized VIM-18).
Topics: Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Humans; India; Microbial Sensitivity Tests; Molecular Sequence Data; Prevalence; Pseudomonas aeruginosa; Ribotyping | 2009 |
Azithromycin in Pseudomonas aeruginosa biofilms: bactericidal activity and selection of nfxB mutants.
Topics: Anti-Bacterial Agents; Azithromycin; Bacterial Proteins; Biofilms; Cefepime; Cephalosporins; Ciprofloxacin; Cystic Fibrosis; DNA-Binding Proteins; Humans; Membrane Proteins; Membrane Transport Proteins; Microbial Sensitivity Tests; Mutation; MutS DNA Mismatch-Binding Protein; Pseudomonas aeruginosa; Transcription Factors | 2009 |
First organisms with acquired metallo-beta-lactamases (IMP-13, IMP-22, and VIM-2) reported in Austria.
Topics: Austria; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Pseudomonas aeruginosa; Pseudomonas Infections; Sequence Analysis, DNA | 2009 |
Efflux unbalance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactams; Cystic Fibrosis; Gene Expression Regulation, Bacterial; Humans; Membrane Transport Proteins; Microbial Sensitivity Tests; Mutation; Pseudomonas aeruginosa; Pseudomonas Infections; Sputum | 2009 |
Prevalence of aac(6')-Ib-cr encoding a ciprofloxacin-modifying enzyme among Enterobacteriaceae blood isolates in Korea.
Topics: Acetyltransferases; beta-Lactamases; Ciprofloxacin; Conjugation, Genetic; Enterobacteriaceae; Microbial Sensitivity Tests; Plasmids | 2009 |
Antibiotic resistance in Pseudomonas aeruginosa strains with increased mutation frequency due to inactivation of the DNA oxidative repair system.
Topics: Cystic Fibrosis; DNA Repair; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Mutation; Neutrophil Activation; Oxidation-Reduction; Oxidative Stress; Pseudomonas aeruginosa | 2009 |
AbaR5, a large multiple-antibiotic resistance region found in Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Base Sequence; DNA Transposable Elements; Drug Resistance, Multiple, Bacterial; Molecular Sequence Data; Multigene Family; Polymerase Chain Reaction | 2009 |
Molecular characteristics of travel-related extended-spectrum-beta-lactamase-producing Escherichia coli isolates from the Calgary Health Region.
Topics: beta-Lactamases; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Fluoroquinolones; Humans; Travel | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Besifloxacin, a novel fluoroquinolone, has broad-spectrum in vitro activity against aerobic and anaerobic bacteria.
Topics: Anti-Bacterial Agents; Azepines; Bacteria, Anaerobic; Drug Resistance, Bacterial; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests | 2009 |
Role of porins in the susceptibility of Mycobacterium smegmatis and Mycobacterium chelonae to aldehyde-based disinfectants and drugs.
Topics: Antitubercular Agents; Disinfectants; Drug Resistance, Bacterial; Glutaral; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Mycobacterium chelonae; Mycobacterium smegmatis; o-Phthalaldehyde; Porins | 2009 |
Complete nucleotide sequences of plasmids pEK204, pEK499, and pEK516, encoding CTX-M enzymes in three major Escherichia coli lineages from the United Kingdom, all belonging to the international O25:H4-ST131 clone.
Topics: beta-Lactamases; Computational Biology; Escherichia coli; Models, Genetic; Molecular Sequence Data; Open Reading Frames; Plasmids; United Kingdom | 2009 |
High prevalence of CTX-M-type beta-lactamases among clinical isolates of Enterobacteriaceae in Bamako, Mali.
Topics: beta-Lactamases; Drug Resistance, Bacterial; Enterobacteriaceae; Humans; Random Amplified Polymorphic DNA Technique | 2009 |
Nosocomial spread of colistin-only-sensitive sequence type 235 Pseudomonas aeruginosa isolates producing the extended-spectrum beta-lactamases GES-1 and GES-5 in Spain.
Topics: Anti-Bacterial Agents; Base Sequence; beta-Lactamases; Colistin; Cross Infection; Humans; Molecular Sequence Data; Pseudomonas aeruginosa | 2009 |
Alterations in two-component regulatory systems of phoPQ and pmrAB are associated with polymyxin B resistance in clinical isolates of Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Gene Expression Regulation, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Polymyxin B; Pseudomonas aeruginosa; Pseudomonas Infections; Transcription Factors | 2009 |
Detection of the novel extended-spectrum beta-lactamase OXA-161 from a plasmid-located integron in Pseudomonas aeruginosa clinical isolates from Spain.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; beta-Lactamases; Cefepime; Cephalosporins; Clavulanic Acid; Gentamicins; Humans; Imipenem; Integrons; Meropenem; Molecular Sequence Data; Penicillanic Acid; Piperacillin; Plasmids; Pseudomonas aeruginosa; Pseudomonas Infections; Spain; Tazobactam; Thienamycins | 2009 |
In vivo efficacy of 1- and 2-gram human simulated prolonged infusions of doripenem against Pseudomonas aeruginosa.
Topics: Animals; Anti-Bacterial Agents; Carbapenems; Doripenem; Drug Administration Schedule; Female; Humans; Mice; Pseudomonas aeruginosa; Pseudomonas Infections | 2009 |
ACHN-490, a neoglycoside with potent in vitro activity against multidrug-resistant Klebsiella pneumoniae isolates.
Topics: Aminoglycosides; Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Structure | 2009 |
In vitro pharmacodynamics of levofloxacin and other aerosolized antibiotics under multiple conditions relevant to chronic pulmonary infection in cystic fibrosis.
Topics: Aerosols; Anti-Bacterial Agents; Bacteria; Biofilms; Chronic Disease; Ciprofloxacin; Colony Count, Microbial; Cystic Fibrosis; Humans; Levofloxacin; Lung Diseases; Microbial Sensitivity Tests; Ofloxacin; Sputum | 2010 |
Klebsiella pneumoniae AcrAB efflux pump contributes to antimicrobial resistance and virulence.
Topics: Animals; Anti-Bacterial Agents; Bronchoalveolar Lavage Fluid; Culture Media; Defensins; DNA, Bacterial; Drug Resistance, Bacterial; Genotype; Humans; Klebsiella Infections; Klebsiella pneumoniae; Lipopolysaccharides; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Phenotype; Plasmids; Polymyxin B; Polysaccharides; Repressor Proteins; RNA, Bacterial | 2010 |
Screening and quantification of the expression of antibiotic resistance genes in Acinetobacter baumannii with a microarray.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; DNA, Bacterial; DNA, Complementary; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Genes, MDR; Metals, Heavy; Microbial Sensitivity Tests; Mutation; Oligonucleotide Array Sequence Analysis; Reproducibility of Results; Reverse Transcriptase Polymerase Chain Reaction; RNA, Bacterial | 2010 |
Molecular epidemiology of metallo-beta-lactamase-producing Pseudomonas aeruginosa isolates from Norway and Sweden shows import of international clones and local clonal expansion.
Topics: Alleles; beta-Lactamases; Conjugation, Genetic; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Microbial Sensitivity Tests; Molecular Epidemiology; Norway; Pseudomonas aeruginosa; Pseudomonas Infections; Serotyping; Sweden | 2010 |
In vitro potency of CXA-101, a novel cephalosporin, against Pseudomonas aeruginosa displaying various resistance phenotypes, including multidrug resistance.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Cephalosporins; Child; Child, Preschool; Cross Infection; Drug Combinations; Drug Resistance, Multiple, Bacterial; Humans; Infant; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Pseudomonas aeruginosa; Tazobactam; Young Adult | 2010 |
Activity of a new antipseudomonal cephalosporin, CXA-101 (FR264205), against carbapenem-resistant and multidrug-resistant Pseudomonas aeruginosa clinical strains.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cephalosporins; Drug Resistance, Multiple, Bacterial; Humans; Isoelectric Focusing; Microbial Sensitivity Tests; Polymerase Chain Reaction; Pseudomonas aeruginosa; Pseudomonas Infections | 2010 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Acinetobacter baumannii increases tolerance to antibiotics in response to monovalent cations.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacterial Proteins; Cations, Monovalent; Culture Media; Drug Resistance, Bacterial; Gene Expression Profiling; Gene Expression Regulation, Bacterial; Humans; Microbial Sensitivity Tests; Oligonucleotide Array Sequence Analysis; Proteomics; Sodium Chloride; Virulence Factors | 2010 |
The chemical synthesis and antibiotic activity of a diverse library of 2-aminobenzimidazole small molecules against MRSA and multidrug-resistant A. baumannii.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Benzimidazoles; Drug Resistance, Multiple, Bacterial; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Conformation; Small Molecule Libraries; Stereoisomerism; Structure-Activity Relationship | 2010 |
High prevalence of ST131 isolates producing CTX-M-15 and CTX-M-14 among extended-spectrum-beta-lactamase-producing Escherichia coli isolates from Canada.
Topics: Bacterial Typing Techniques; beta-Lactamases; Canada; Community-Acquired Infections; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests; Prevalence; Urinary Tract Infections | 2010 |
Efflux pumps, OprD porin, AmpC beta-lactamase, and multiresistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.
Topics: Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactamases; Cystic Fibrosis; Drug Resistance, Bacterial; Drug Resistance, Multiple; Electrophoresis, Gel, Pulsed-Field; Humans; Membrane Transport Proteins; Mutation; Porins; Pseudomonas aeruginosa; Pseudomonas Infections; Reverse Transcriptase Polymerase Chain Reaction; Up-Regulation | 2010 |
Genetic basis of multidrug resistance in Acinetobacter clinical isolates in Taiwan.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aminoglycosides; beta-Lactamases; Carbapenems; Cephalosporins; DNA Gyrase; Drug Resistance, Bacterial; Drug Resistance, Multiple; Fluoroquinolones; Humans; Taiwan | 2010 |
Molecular characterization of beta-lactamase genes and their genetic structures in Acinetobacter genospecies 3 isolates in Taiwan.
Topics: Acinetobacter; Acinetobacter Infections; beta-Lactam Resistance; beta-Lactamases; Cephalosporinase; Gene Transfer, Horizontal; Genes, Bacterial; Humans; In Vitro Techniques; Integrons; Microbial Sensitivity Tests; Molecular Epidemiology; Molecular Sequence Data; Phylogeny; Taiwan | 2010 |
In vitro activity of the aminoglycoside antibiotic arbekacin against Acinetobacter baumannii-calcoaceticus isolated from war-wounded patients at Walter Reed Army Medical Center.
Topics: Acinetobacter baumannii; Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Dibekacin; Hospitals, Military; Humans; Microbial Sensitivity Tests; Warfare | 2010 |
First survey of metallo-beta-lactamases in clinical isolates of Pseudomonas aeruginosa in a German university hospital.
Topics: Anti-Bacterial Agents; beta-Lactamases; Ceftazidime; Drug Resistance, Bacterial; Germany; Hospitals, University; Humans; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections | 2010 |
Foreign travel is a major risk factor for colonization with Escherichia coli producing CTX-M-type extended-spectrum beta-lactamases: a prospective study with Swedish volunteers.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; beta-Lactamases; Child; Child, Preschool; Escherichia coli; Escherichia coli Infections; Female; Humans; Male; Middle Aged; Prospective Studies; Risk Factors; Sweden; Travel; White People; Young Adult | 2010 |
The development of ciprofloxacin resistance in Pseudomonas aeruginosa involves multiple response stages and multiple proteins.
Topics: Anti-Infective Agents; Bacterial Proteins; Ciprofloxacin; DNA, Bacterial; Drug Resistance, Bacterial; Electrophoresis, Gel, Two-Dimensional; Methylmalonate-Semialdehyde Dehydrogenase (Acylating); Microbial Sensitivity Tests; Pseudomonas aeruginosa; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Succinate-Semialdehyde Dehydrogenase | 2010 |
Frequency of spontaneous resistance to fosfomycin combined with different antibiotics in Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Fosfomycin; Mutation; Pseudomonas aeruginosa | 2010 |
In vivo selection of a missense mutation in adeR and conversion of the novel blaOXA-164 gene into blaOXA-58 in carbapenem-resistant Acinetobacter baumannii isolates from a hospitalized patient.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Bacterial Proteins; Carbapenems; Drug Resistance, Bacterial; Fatal Outcome; Humans; Male; Middle Aged; Molecular Sequence Data; Mutation, Missense; Reverse Transcriptase Polymerase Chain Reaction | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Synthesis and antimicrobial profile of N-substituted imidazolium oximes and their monoquaternary salts against multidrug resistant bacteria.
Topics: Anti-Infective Agents; Bacterial Infections; Drug Resistance, Multiple; Fungi; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imidazoles; Microbial Sensitivity Tests; Mycoses; Oximes | 2013 |
Thiol activated prodrugs of sulfur dioxide (SO2) as MRSA inhibitors.
Topics: Anti-Bacterial Agents; Drug Design; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Prodrugs; Staphylococcal Infections; Structure-Activity Relationship; Sulfhydryl Compounds; Sulfur Dioxide | 2015 |
An efficient green synthesis of 2-arylbenzothiazole analogues as potent antibacterial and anticancer agents.
Topics: Anti-Bacterial Agents; Antineoplastic Agents; Bacillus subtilis; Benzothiazoles; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Escherichia coli; Green Chemistry Technology; HeLa Cells; Humans; MCF-7 Cells; Microbial Sensitivity Tests; Molecular Structure; Salmonella; Staphylococcus aureus; Structure-Activity Relationship | 2016 |
Hybrid Antibiotic Overcomes Resistance in P. aeruginosa by Enhancing Outer Membrane Penetration and Reducing Efflux.
Topics: Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Humans; Moxifloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin | 2016 |
New Broad-Spectrum Antibacterial Amphiphilic Aminoglycosides Active against Resistant Bacteria: From Neamine Derivatives to Smaller Neosamine Analogues.
Topics: Aminoglycosides; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Framycetin; Glucosamine; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Surface-Active Agents | 2016 |
Diaryltriazenes as antibacterial agents against methicillin resistant Staphylococcus aureus (MRSA) and Mycobacterium smegmatis.
Topics: Anti-Bacterial Agents; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mycobacterium smegmatis; Triazenes | 2017 |
Prediction of Antibiotic Interactions Using Descriptors Derived from Molecular Structure.
Topics: Anti-Bacterial Agents; Drug Interactions; Molecular Structure | 2017 |
Amphiphilic Tobramycin-Lysine Conjugates Sensitize Multidrug Resistant Gram-Negative Bacteria to Rifampicin and Minocycline.
Topics: Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Hemolysis; Lysine; Microbial Sensitivity Tests; Minocycline; Models, Biological; Rifampin; Tobramycin | 2017 |
Design, Synthesis, and Properties of a Potent Inhibitor of Pseudomonas aeruginosa Deacetylase LpxC.
Topics: Amidohydrolases; Animals; Anti-Bacterial Agents; Chemistry Techniques, Synthetic; Crystallography, X-Ray; Drug Design; Drug Evaluation, Preclinical; Drug Resistance, Multiple, Bacterial; Enzyme Inhibitors; Female; Hep G2 Cells; Humans; K562 Cells; Mice, Inbred BALB C; Microbial Sensitivity Tests; Molecular Docking Simulation; Pseudomonas aeruginosa; Pseudomonas Infections; Structure-Activity Relationship | 2017 |
Broad-spectrum antibacterial amphiphilic aminoglycosides: A new focus on the structure of the lipophilic groups extends the series of active dialkyl neamines.
Topics: Aminoglycosides; Anti-Bacterial Agents; Cell Survival; Dose-Response Relationship, Drug; Eukaryotic Cells; Framycetin; Humans; Microbial Sensitivity Tests; Molecular Structure; Pseudomonas aeruginosa; Structure-Activity Relationship; Surface-Active Agents | 2018 |
Homodimeric Tobramycin Adjuvant Repurposes Novobiocin as an Effective Antibacterial Agent against Gram-Negative Bacteria.
Topics: Anti-Bacterial Agents; Dimerization; Gram-Negative Bacteria; Novobiocin; Tobramycin | 2019 |
Design, synthesis, and biological evaluation of 3-amino-2-oxazolidinone derivatives as potent quorum-sensing inhibitors of Pseudomonas aeruginosa PAO1.
Topics: Anti-Bacterial Agents; Biofilms; Dose-Response Relationship, Drug; Drug Design; Microbial Sensitivity Tests; Molecular Structure; Oxazolidinones; Pseudomonas aeruginosa; Quorum Sensing; Structure-Activity Relationship | 2020 |
Overcoming β-Lactam resistance in Pseudomonas aeruginosa using non-canonical tobramycin-based antibiotic adjuvants.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Structure; Pseudomonas aeruginosa; Structure-Activity Relationship; Tobramycin | 2020 |
New
Topics: Animals; Anti-Bacterial Agents; Biofilms; Cell Line; Cell Survival; Colony Count, Microbial; Drug Resistance, Multiple, Bacterial; Drug Synergism; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Pyocyanine; Pyridines; Quinolones; Quorum Sensing; Zebrafish | 2022 |
Amphiphilic cyclic peptide [W
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Gram-Negative Bacteria; Gram-Positive Bacteria; Meropenem; Microbial Sensitivity Tests; Peptides, Cyclic; Pseudomonas aeruginosa | 2022 |
Effect of polysaccharide interactions on antibiotic susceptibility of Pseudomonas aeruginosa.
Topics: Burkholderia cepacia; Cations; Ciprofloxacin; Drug Interactions; Drug Resistance, Microbial; Microbial Sensitivity Tests; Polysaccharides, Bacterial; Pseudomonas aeruginosa; Tobramycin; Viscosity | 1992 |
Post-antibiotic effect of ceftazidime, ciprofloxacin, imipenem, piperacillin and tobramycin for Pseudomonas cepacia.
Topics: Burkholderia cepacia; Ceftazidime; Ciprofloxacin; Cystic Fibrosis; Humans; Imipenem; Microbial Sensitivity Tests; Piperacillin; Tobramycin | 1992 |
Effect of biofilm culture upon the susceptibility of Staphylococcus epidermidis to tobramycin.
Topics: Ciprofloxacin; Colony Count, Microbial; Microbial Sensitivity Tests; Staphylococcus epidermidis; Tobramycin | 1992 |
Killing curve activity of ciprofloxacin is comparable to synergistic effect of beta-lactam-tobramycin combinations against Haemophilus species endocarditis strains.
Topics: Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Drug Synergism; Endocarditis, Bacterial; Haemophilus; Humans; Microbial Sensitivity Tests; Tobramycin | 1992 |
In vitro interactions of aminoglycosides with imipenem or ciprofloxacin against aminoglycoside resistant Acinetobacter baumannii.
Topics: Acinetobacter; Amikacin; Anti-Bacterial Agents; Ciprofloxacin; Drug Interactions; Drug Resistance, Microbial; Gentamicins; Humans; Imipenem; Microbial Sensitivity Tests; Netilmicin; Tobramycin | 1992 |
In vitro and in vivo evaluation of antibiotic diffusion from antibiotic-impregnated polymethylmethacrylate beads.
Topics: Animals; Anti-Bacterial Agents; Bone and Bones; Cefazolin; Ciprofloxacin; Clindamycin; Diffusion; Dogs; Granulation Tissue; Methylmethacrylates; Ticarcillin; Tobramycin; Vancomycin | 1992 |
Compatibility of ciprofloxacin injection with selected drugs and solutions.
Topics: Amikacin; Anti-Bacterial Agents; Ciprofloxacin; Clindamycin; Drug Compounding; Drug Incompatibility; Drug Stability; Drug Storage; Drug Therapy, Combination; Gentamicins; Metronidazole; Solutions; Theophylline; Tobramycin | 1991 |
Mathematical examination of dual individualization principles (I): Relationships between AUC above MIC and area under the inhibitory curve for cefmenoxime, ciprofloxacin, and tobramycin.
Topics: Cefmenoxime; Ciprofloxacin; Computer Simulation; Kinetics; Microbial Sensitivity Tests; Models, Theoretical; Tobramycin | 1991 |
[Otitis externa maligna. Report of a case resistant to ciprofloxacin].
Topics: Aged; Aged, 80 and over; Ceftazidime; Ciprofloxacin; Diabetes Mellitus, Type 1; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Otitis Externa; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin | 1991 |
The efficacy of topical ciprofloxacin and norfloxacin in the treatment of experimental Pseudomonas keratitis.
Topics: Administration, Topical; Animals; Ciprofloxacin; Colony Count, Microbial; Keratitis; Norfloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Tobramycin | 1991 |
Comparison of inhibitory and bactericidal activity of antipseudomonal antibiotics against Pseudomonas aeruginosa isolates from cystic fibrosis patients.
Topics: Amikacin; Ciprofloxacin; Cystic Fibrosis; Drug Resistance, Microbial; Humans; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Tobramycin | 1990 |
Comparative in vitro activity of the new quinolone sparfloxacin (CI-978, AT-4140) against nosocomial gram-negative bloodstream isolates.
Topics: Amikacin; Anti-Infective Agents; Cephalosporins; Ciprofloxacin; Cross Infection; Enterobacteriaceae; Fluoroquinolones; Gram-Negative Bacteria; Humans; Imipenem; Pseudomonas aeruginosa; Sepsis; Tobramycin | 1990 |
Quinolones in collagen shields to treat aminoglycoside-resistant pseudomonal keratitis.
Topics: Animals; Ciprofloxacin; Collagen; Colony Count, Microbial; Cornea; Drug Resistance, Microbial; Eye Infections, Bacterial; Keratitis; Norfloxacin; Pharmaceutical Vehicles; Pseudomonas aeruginosa; Quinolones; Rabbits; Tobramycin | 1990 |
Treatment of experimental Escherichia coli pyelonephritis in rat by ciprofloxacin in comparison with tobramycin.
Topics: Animals; Ciprofloxacin; Drug Administration Schedule; Escherichia coli Infections; Injections, Intravenous; Male; Pyelonephritis; Rats; Rats, Inbred Strains; Tobramycin | 1990 |
In vitro selection of resistant Helicobacter pylori.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Microbial; Erythromycin; Helicobacter pylori; Metronidazole; Microbial Sensitivity Tests; Serial Passage; Tobramycin | 1990 |
Superinfection with Streptococcus pneumoniae during therapy with ciprofloxacin.
Topics: Ciprofloxacin; Humans; Male; Middle Aged; Pneumonia; Pneumonia, Pneumococcal; Pseudomonas Infections; Streptococcal Infections; Streptococcus pneumoniae; Superinfection; Tobramycin | 1990 |
Inhibition of Pseudomonas aeruginosa exoenzyme expression by subinhibitory antibiotic concentrations.
Topics: ADP Ribose Transferases; Animals; Bacterial Toxins; Ceftazidime; Ciprofloxacin; Dose-Response Relationship, Drug; Exotoxins; Lung; Male; Pancreatic Elastase; Poly(ADP-ribose) Polymerase Inhibitors; Protease Inhibitors; Pseudomonas aeruginosa; Pseudomonas aeruginosa Exotoxin A; Pseudomonas Infections; Rats; Rats, Inbred Strains; Time Factors; Tobramycin; Type C Phospholipases; Virulence Factors | 1989 |
L-658,310, a new injectable cephalosporin. II. In vitro and in vivo interactions between L-658,310 and various aminoglycosides or ciprofloxacin versus clinical isolates of Pseudomonas aeruginosa.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Cephalosporins; Ciprofloxacin; Drug Synergism; Female; Gentamicins; Isoindoles; Mice; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin | 1989 |
In vitro activity of fleroxacin and 6 other antimicrobials against Acinetobacter anitratus.
Topics: Acinetobacter; Anti-Bacterial Agents; Cefepime; Ceftazidime; Ceftriaxone; Cephalosporins; Ciprofloxacin; Enoxacin; Fleroxacin; Humans; Microbial Sensitivity Tests; Ofloxacin; Tobramycin | 1989 |
Effects of sub-inhibitory concentrations of antibiotics on surface expression of ferripyochelin-binding protein in Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Bacterial Proteins; Carrier Proteins; Chloramphenicol; Ciprofloxacin; Electrophoresis, Polyacrylamide Gel; Gene Expression Regulation, Bacterial; Immunoblotting; Indicators and Reagents; Iron Radioisotopes; Lipopolysaccharides; Membrane Proteins; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Tetracycline; Tobramycin; Topoisomerase II Inhibitors | 1989 |
Ciprofloxacin for Pseudomonas aeruginosa meningitis.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Therapy, Combination; Humans; Male; Meningitis; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolines; Tobramycin | 1986 |
Influence of faeces on the activity of antimicrobial agents used for decontamination of the alimentary canal.
Topics: Anti-Bacterial Agents; Aztreonam; Ciprofloxacin; Colistin; Digestive System; Dose-Response Relationship, Drug; Feces; Humans; Nalidixic Acid; Neomycin; Norfloxacin; Pipemidic Acid; Quinolines; Tobramycin | 1985 |
Comparison of ciprofloxacin with azlocillin plus tobramycin in the therapy of experimental Pseudomonas aeruginosa endocarditis.
Topics: Animals; Azlocillin; Ciprofloxacin; Drug Therapy, Combination; Endocarditis, Bacterial; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolines; Rabbits; Tobramycin | 1985 |
Antimicrobial activity of ciprofloxacin against Pseudomonas aeruginosa, Escherichia coli, and Staphylococcus aureus determined by the killing curve method: antibiotic comparisons and synergistic interactions.
Topics: Azlocillin; Aztreonam; Ciprofloxacin; Drug Synergism; Escherichia coli; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Quinolines; Staphylococcus aureus; Tobramycin | 1985 |
Assessment of the in vitro and in vivo activity of ciprofloxacin measured against current standards of therapy.
Topics: Ampicillin; Animals; Azlocillin; Blood; Ciprofloxacin; Escherichia coli; Humans; In Vitro Techniques; Mice; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin; Oxazines; Pseudomonas aeruginosa; Quinolines; Sisomicin; Tobramycin | 1985 |
The effect of anaerobiosis on antistaphylococcal antibiotics.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anaerobiosis; Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Clavulanic Acids; Clindamycin; Coagulase; Drug Therapy, Combination; Glycopeptides; Microbial Sensitivity Tests; Staphylococcus; Teicoplanin; Ticarcillin; Tobramycin; Vancomycin | 1988 |
Ciprofloxacin in the treatment of Pseudomonas infection in cystic fibrosis patients.
Topics: Adolescent; Adult; Azlocillin; Ciprofloxacin; Cystic Fibrosis; Drug Therapy, Combination; Humans; Pseudomonas; Pseudomonas aeruginosa; Pseudomonas Infections; Sputum; Tobramycin | 1986 |
Ciprofloxacin in experimental Pseudomonas aeruginosa meningitis in rabbits.
Topics: Animals; Ceftazidime; Ciprofloxacin; Disease Models, Animal; Meningitis; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Tobramycin | 1986 |
Comparative efficacy of ciprofloxacin, azlocillin, and tobramycin alone and in combination in experimental Pseudomonas sepsis.
Topics: Animals; Azlocillin; Ciprofloxacin; Drug Synergism; Drug Therapy, Combination; Female; Pseudomonas aeruginosa; Pseudomonas Infections; Rats; Rats, Inbred Strains; Tobramycin | 1987 |
Post-antibiotic effect of ciprofloxacin on Pseudomonas aeruginosa.
Topics: Ciprofloxacin; Kinetics; Microbial Sensitivity Tests; Piperacillin; Pseudomonas aeruginosa; Tobramycin | 1987 |
Analysis of the interaction between piperacillin and ciprofloxacin or tobramycin against thirteen strains of Pseudomonas aeruginosa, using killing curves.
Topics: Ciprofloxacin; Drug Synergism; In Vitro Techniques; Microbial Sensitivity Tests; Piperacillin; Pseudomonas aeruginosa; Tobramycin | 1987 |
The activity of ciprofloxacin against Pseudomonas aeruginosa in normal and granulocytopenic mice.
Topics: Agranulocytosis; Animals; Ciprofloxacin; Male; Mice; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin | 1987 |
The relative efficacies of tobramycin and ciprofloxacin against Pseudomonas aeruginosa in vitro and in normal and granulocytopenic mice.
Topics: Agranulocytosis; Animals; Ciprofloxacin; Mice; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin | 1988 |
[Comparative bactericidal activity of imipenem and other antibiotics against Pseudomonas aeruginosa].
Topics: Amikacin; Anti-Bacterial Agents; Ceftazidime; Ciprofloxacin; Drug Resistance, Microbial; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Thienamycins; Ticarcillin; Tobramycin | 1988 |
Ciprofloxacin as therapy for experimental osteomyelitis caused by Pseudomonas aeruginosa.
Topics: Animals; Anti-Bacterial Agents; Bone and Bones; Chronic Disease; Ciprofloxacin; Drug Resistance, Microbial; Osteomyelitis; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolines; Rabbits; Tobramycin | 1985 |
Interaction between ciprofloxacin and tobramycin or azlocillin against multiresistant strains of Acinetobacter anitratum in vitro.
Topics: Acinetobacter; Azlocillin; Ciprofloxacin; Drug Synergism; Microbial Sensitivity Tests; Quinolines; Tobramycin | 1985 |
[Ciprofloxacin in combination with other antimicrobial substances].
Topics: Anti-Bacterial Agents; Azlocillin; Bacteria; Ciprofloxacin; Drug Interactions; Imipenem; Mezlocillin; Microbial Sensitivity Tests; Thienamycins; Tobramycin | 1988 |
Lack of correlation between objective indicators and clinical-response scores during antimicrobial therapy for acute pulmonary exacerbations of cystic fibrosis.
Topics: Anti-Bacterial Agents; Azlocillin; Aztreonam; Ciprofloxacin; Cystic Fibrosis; Humans; Tobramycin | 1988 |
Comparison of two methods for determining in vitro postantibiotic effects of three antibiotics on Escherichia coli.
Topics: Ampicillin; Ciprofloxacin; Escherichia coli; Microbial Sensitivity Tests; Spectrophotometry; Time Factors; Tobramycin | 1988 |
In vitro activity of two new aryl-fluoroquinolone antimicrobial agents, difloxacin (A-56619) and A-56620 compared to that of other antimicrobial agents.
Topics: Anti-Bacterial Agents; Bacteria; Bacteriological Techniques; Ciprofloxacin; Drug Resistance, Microbial; Fluoroquinolones; Microbial Sensitivity Tests; Quinolines; Tobramycin | 1987 |
In vitro susceptibilities of 393 recent clinical isolates to WIN 49375, cefotaxime, tobramycin, and piperacillin.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cefotaxime; Ciprofloxacin; Enterobacteriaceae; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Piperacillin; Pseudomonas; Quinolines; Staphylococcus; Tobramycin | 1984 |
Comparative activities of ciprofloxacin, ticarcillin, and tobramycin against experimental Pseudomonas aeruginosa pneumonia.
Topics: Animals; Anti-Bacterial Agents; Ciprofloxacin; Guinea Pigs; Kinetics; Pneumonia; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolines; Ticarcillin; Tobramycin | 1984 |
Effect of sub-MIC antibiotics on the cell surface and extracellular virulence determinants of Pseudomonas cepacia.
Topics: Burkholderia cepacia; Ciprofloxacin; Dose-Response Relationship, Drug; Tobramycin; Virulence | 1994 |
Different patterns of bacterial DNA synthesis during postantibiotic effect.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Dicloxacillin; DNA, Bacterial; Escherichia coli; Gentamicins; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Rifampin; Staphylococcus aureus; Tobramycin; Vancomycin | 1995 |
Effectiveness of specific antibiotic/steroid combinations for therapy of experimental Pseudomonas aeruginosa keratitis.
Topics: Animals; Anti-Bacterial Agents; Ciprofloxacin; Colony Count, Microbial; Cornea; Dexamethasone; Disease Models, Animal; Drug Therapy, Combination; Eye Infections, Bacterial; Glucocorticoids; Keratitis; Ophthalmic Solutions; Prednisolone; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Tobramycin | 1995 |
Development of antibiotic resistance in Pseudomonas aeruginosa during two decades of antipseudomonal treatment at the Danish CF Center.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbenicillin; Ceftazidime; Ciprofloxacin; Cystic Fibrosis; Denmark; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Piperacillin; Pneumonia, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin | 1994 |
Treatment of acute peritonitis by temporary discontinuation of dialysis and low doses of oral ciprofloxacin in patients on CAPD.
Topics: Acute Disease; Administration, Oral; Bacterial Infections; Cefazolin; Ciprofloxacin; Clinical Protocols; Humans; Infusions, Parenteral; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Tobramycin | 1994 |
Treatment and prevention of relapses of CAPD Pseudomonas peritonitis.
Topics: Ceftazidime; Ciprofloxacin; Drug Therapy, Combination; Female; Humans; Male; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Pseudomonas Infections; Recurrence; Tobramycin | 1993 |
Bioassays for quantitating ciprofloxacin and tobramycin in aqueous humor.
Topics: Animals; Aqueous Humor; Biological Assay; Ciprofloxacin; Klebsiella pneumoniae; Microbial Sensitivity Tests; Rabbits; Reproducibility of Results; Sensitivity and Specificity; Staphylococcus aureus; Tobramycin | 1993 |
Ciprofloxacin versus tobramycin for the treatment of staphylococcal keratitis.
Topics: Animals; Ciprofloxacin; Colony Count, Microbial; Corneal Stroma; Drug Administration Schedule; Eye Infections, Bacterial; Keratitis; Methicillin Resistance; Ophthalmic Solutions; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Tobramycin | 1994 |
Topical ciprofloxacin versus topical fortified antibiotics in rabbit models of Staphylococcus and Pseudomonas keratitis.
Topics: Administration, Topical; Animals; Cefazolin; Ciprofloxacin; Colony Count, Microbial; Cornea; Disease Models, Animal; Drug Therapy, Combination; Eye Infections, Bacterial; Keratitis; Ophthalmic Solutions; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Tobramycin | 1993 |
Antibiotic-induced release of endotoxin from bacteria in vitro.
Topics: Anti-Bacterial Agents; Cefotaxime; Ciprofloxacin; Colony Count, Microbial; Endotoxins; Enterobacter cloacae; Escherichia coli; Humans; Limulus Test; Lipopolysaccharides; Microscopy, Electron, Scanning; Piperacillin; Silver Staining; Tobramycin | 1994 |
Infectious scleritis after a diabetic foot ulcer.
Topics: Administration, Oral; Administration, Topical; Ciprofloxacin; Diabetes Mellitus; Drug Therapy, Combination; Erythromycin; Eye Infections, Bacterial; Foot Ulcer; Humans; Male; Methicillin Resistance; Microbial Sensitivity Tests; Middle Aged; Scleritis; Staphylococcal Infections; Staphylococcus aureus; Tobramycin; Vancomycin | 1993 |
Acute Pseudomonas infection following total hip replacement.
Topics: Acute Disease; Aged; Ciprofloxacin; Drug Delivery Systems; Hip Prosthesis; Humans; Male; Methylmethacrylates; Postoperative Complications; Pseudomonas Infections; Surgical Wound Infection; Tobramycin | 1993 |
Comparison of three different in vitro methods of detecting synergy: time-kill, checkerboard, and E test.
Topics: Bacteria; Cefepime; Ceftazidime; Cephalosporins; Ciprofloxacin; Drug Synergism; Drug Therapy, Combination; Enterobacter cloacae; Escherichia coli; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Staphylococcus aureus; Tobramycin | 1996 |
Postantibiotic effect and virulence factors depression induced by ciprofloxacin and by aminoglycosides in a clinical isolate of Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Endopeptidases; Netilmicin; Pancreatic Elastase; Pseudomonas aeruginosa; Tobramycin; Virulence | 1996 |
AUIC--a general target for the optimization of dosing regimens of antibiotics?
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Cefmenoxime; Cephalosporins; Ciprofloxacin; Drug Administration Schedule; Humans; Microbial Sensitivity Tests; Models, Biological; Tobramycin | 1996 |
In vitro efficacy of levofloxacin alone or in combination tested against multi-resistant Pseudomonas aeruginosa strains.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Aztreonam; Ceftazidime; Ciprofloxacin; Drug Resistance, Multiple; Gentamicins; Humans; Imipenem; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Piperacillin; Pseudomonas aeruginosa; Tobramycin | 1996 |
In-vitro activity of antimicrobial agent combinations against multiresistant Acinetobacter baumannii.
Topics: Acinetobacter; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Ceftazidime; Cephalosporins; Ciprofloxacin; Drug Resistance, Multiple; Drug Therapy, Combination; Fosfomycin; Imipenem; Microbial Sensitivity Tests; Thienamycins; Tobramycin | 1996 |
Postantibiotic effects of subinhibitory concentrations of some antibiotics and their influence on Pseudomonas aeruginosa enzymic activity.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Endopeptidases; Gentamicins; Microbial Sensitivity Tests; Netilmicin; Pancreatic Elastase; Pseudomonas aeruginosa; Tobramycin | 1996 |
Immersion in antibiotic solution prevents bacterial adhesion onto biodegradable prostatic stents.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Adhesion; Biodegradation, Environmental; Ciprofloxacin; Equipment Contamination; Escherichia coli; Humans; Lactic Acid; Male; Polyesters; Polyglycolic Acid; Polymers; Prostatic Diseases; Stents; Tobramycin | 1997 |
The influence of postantibiotic effects and postantibiotic effects of sub-inhibitory concentrations of quinolones and aminoglycosides on phospholipase C of Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Gentamicins; Microbial Sensitivity Tests; Netilmicin; Pefloxacin; Pseudomonas aeruginosa; Tobramycin; Type C Phospholipases | 1997 |
Comparison of antibacterial activities of meropenem and six other antimicrobials against Pseudomonas aeruginosa isolates from North American studies and clinical trials.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Proteins; beta-Lactamases; Ceftazidime; Cephalosporins; Ciprofloxacin; Clinical Trials as Topic; Drug Resistance, Microbial; Gentamicins; Humans; Imipenem; Isoelectric Focusing; Meropenem; Microbial Sensitivity Tests; Penicillins; Piperacillin; Pseudomonas aeruginosa; Thienamycins; Tobramycin | 1997 |
Is it possible to prevent bacterial adhesion onto ureteric stents?
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Adhesion; Bacteriological Techniques; Ceftriaxone; Cephalosporins; Ciprofloxacin; Escherichia coli; Humans; Materials Testing; Stents; Tobramycin; Ureter; Urinary Tract Infections | 1997 |
Correlation between bactericidal activity and postantibiotic effect for five antibiotics with different mechanisms of action.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Dicloxacillin; Dose-Response Relationship, Drug; Escherichia coli; Linear Models; Microbial Sensitivity Tests; Models, Biological; Pseudomonas aeruginosa; Staphylococcus aureus; Tetracycline; Tobramycin; Trimethoprim | 1997 |
Enhancement of Burkholderia cepacia antimicrobial susceptibility by cationic compounds.
Topics: 1-Naphthylamine; Anti-Infective Agents; Azithromycin; Bacterial Outer Membrane Proteins; Burkholderia cepacia; Cations; Ceftazidime; Cell Membrane Permeability; Ciprofloxacin; Clarithromycin; Fleroxacin; Fluorescent Dyes; Fluoroquinolones; Gentamicins; Magnesium; Microbial Sensitivity Tests; Microscopy, Electron; Novobiocin; Oxolinic Acid; Polysaccharides, Bacterial; Tobramycin | 1997 |
Influence of growth rate and nutrient limitation on susceptibility of Burkholderia cepacia to ciprofloxacin and tobramycin.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Burkholderia cepacia; Ciprofloxacin; Culture Media; Microbial Sensitivity Tests; Tobramycin | 1997 |
Influence of the postantibiotic effect and postantibiotic sub-MICs effect of netilmicin, tobramycin, ciprofloxacin and pefloxacin on alginate production by Pseudomonas aeruginosa.
Topics: Alginates; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Cross Infection; Depression, Chemical; Dose-Response Relationship, Drug; Gentamicins; Glucuronic Acid; Hexuronic Acids; Humans; Microbial Sensitivity Tests; Netilmicin; Pefloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin; Virulence | 1996 |
Antibiotic-induced release of endotoxin: in-vitro comparison of meropenem and other antibiotics.
Topics: Anti-Bacterial Agents; Antibodies, Monoclonal; Ceftazidime; Ciprofloxacin; Enzyme-Linked Immunosorbent Assay; Escherichia coli; Imipenem; Lipopolysaccharides; Meropenem; Microbial Sensitivity Tests; O Antigens; Thienamycins; Tobramycin | 1998 |
Scleral buckle infection with ciprofloxacin-resistant Pseudomonas aeruginosa.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Eye Infections, Bacterial; Humans; Male; Microbial Sensitivity Tests; Prosthesis-Related Infections; Pseudomonas aeruginosa; Pseudomonas Infections; Retinal Detachment; Scleral Buckling; Tobramycin | 1998 |
[Corneal penetration of various aminoglycosides and quinolones].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antibiotic Prophylaxis; Aqueous Humor; Cataract Extraction; Ciprofloxacin; Contact Lenses; Cornea; Dose-Response Relationship, Drug; Drug Delivery Systems; Gentamicins; Humans; Microbial Sensitivity Tests; Ofloxacin; Ophthalmic Solutions; Tobramycin | 1998 |
Comparative in vitro activities of meropenem, imipenem, temocillin, piperacillin, and ceftazidime in combination with tobramycin, rifampin, or ciprofloxacin against Burkholderia cepacia isolates from patients with cystic fibrosis.
Topics: Burkholderia cepacia; Burkholderia Infections; Ceftazidime; Ciprofloxacin; Cystic Fibrosis; Drug Synergism; Drug Therapy, Combination; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Penicillins; Piperacillin; Rifampin; Thienamycins; Tobramycin | 1999 |
Multisite reproducibility of results obtained by the broth microdilution method for susceptibility testing of Mycobacterium abscessus, Mycobacterium chelonae, and Mycobacterium fortuitum.
Topics: Amikacin; Anti-Bacterial Agents; Cefoxitin; Ciprofloxacin; Clarithromycin; Culture Media; Doxycycline; Humans; Imipenem; Microbial Sensitivity Tests; Mycobacterium chelonae; Mycobacterium fortuitum; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Sulfamethoxazole; Tobramycin | 1999 |
Development of resistance and cross-resistance in Pseudomonas aeruginosa exposed to subinhibitory antibiotic concentrations.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azlocillin; Ceftazidime; Cephalosporins; Ciprofloxacin; Cystic Fibrosis; Drug Resistance, Microbial; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Penicillins; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin | 1999 |
Tympanostomy tubes and otic suspensions: do they reach the middle ear space?
Topics: Administration, Topical; Anti-Bacterial Agents; Ciprofloxacin; Dexamethasone; Drug Combinations; Ear, Middle; Humans; Hydrocortisone; Middle Ear Ventilation; Neomycin; Otitis Media, Suppurative; Polymyxin B; Postoperative Complications; Therapeutic Irrigation; Tobramycin | 2000 |
Shifting trends in bacterial keratitis in south Florida and emerging resistance to fluoroquinolones.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Ciprofloxacin; Cornea; Corneal Ulcer; Drug Resistance, Microbial; Eye Infections, Bacterial; Florida; Gentamicins; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Ofloxacin; Retrospective Studies; Tobramycin | 2000 |
Methicillin-resistant Staphylococcus aureus otorrhea after tympanostomy tube placement: an emerging concern.
Topics: Administration, Oral; Administration, Topical; Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Child; Child, Preschool; Chloramphenicol; Chloramphenicol Resistance; Ciprofloxacin; Dexamethasone; Drug Therapy, Combination; Humans; Infant; Methicillin; Methicillin Resistance; Middle Ear Ventilation; Otitis Media with Effusion; Postoperative Complications; Staphylococcal Infections; Staphylococcus aureus; Time Factors; Tobramycin | 2000 |
Nosocomial spread of an unusual methicillin-resistant Staphylococcus aureus clone that is sensitive to all non-beta-lactam antibiotics, including tobramycin.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Cross Infection; Electrophoresis, Gel, Pulsed-Field; Genotype; Greece; Hospitals, General; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Oxacillin; Polymerase Chain Reaction; Staphylococcal Infections; Staphylococcus aureus; Tetracycline; Tobramycin | 2001 |
Ultraviolet recall-like phenomenon occurring after piperacillin, tobramycin, and ciprofloxacin therapy.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Drug Eruptions; Erythema; Female; Humans; Methylprednisolone; Penicillins; Piperacillin; Tobramycin; Ultraviolet Rays | 2001 |
Risk of endotoxemia during the initial phase of gut decontamination with antimicrobial agents.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Translocation; Blood Pressure; Ciprofloxacin; Decontamination; Endotoxemia; Escherichia coli Infections; Intestines; Male; Polymyxin B; Rats; Rats, Wistar; Tobramycin | 2001 |
A simple infection model using pre-colonized implants to reproduce rat chronic Staphylococcus aureus osteomyelitis and study antibiotic treatment.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Biofilms; Cefuroxime; Cephalosporins; Chronic Disease; Ciprofloxacin; Disease Models, Animal; Male; Osteomyelitis; Rats; Rats, Wistar; Staphylococcal Infections; Staphylococcus aureus; Tibia; Tobramycin; Vancomycin | 2001 |
Bacillus cereus keratitis associated with contact lens wear.
Topics: Bacillaceae Infections; Bacillus cereus; Ciprofloxacin; Conjunctiva; Contact Lens Solutions; Contact Lenses, Hydrophilic; Cornea; Corneal Ulcer; Disinfection; DNA, Bacterial; Drug Therapy, Combination; Equipment Contamination; Eye Infections, Bacterial; Hot Temperature; Humans; Keratitis; Male; Microbial Sensitivity Tests; Middle Aged; Polymerase Chain Reaction; Tobramycin | 2001 |
Effects of antibiotics on morphologic characteristics and migration of canine corneal epithelial cells in tissue culture.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Cefazolin; Cell Movement; Cephalosporins; Chloramphenicol; Ciprofloxacin; Cornea; Culture Techniques; Dogs; Epithelial Cells; Gentamicins; Statistics, Nonparametric; Tobramycin | 2001 |
Early Pseudomonas aeruginosa colonisation in cystic fibrosis patients.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Child; Ciprofloxacin; Clinical Trials as Topic; Colistin; Cystic Fibrosis; Humans; Pseudomonas Infections; Tobramycin | 2002 |
Summaries for patients. Treatment of fever in hospitalized patients with low white blood cell counts.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Bone Marrow Transplantation; Ciprofloxacin; Drug Therapy, Combination; Female; Fever; Humans; Leukemia; Lymphoma; Male; Middle Aged; Neutropenia; Opportunistic Infections; Penicillins; Piperacillin; Tobramycin | 2002 |
Analogy between temperature-dependent and concentration-dependent bacterial killing.
Topics: Anti-Bacterial Agents; Bacteriolysis; Ceftazidime; Ciprofloxacin; Computer Simulation; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Microbial; Humans; Microbial Sensitivity Tests; Sterilization; Temperature; Time Factors; Tobramycin | 2002 |
Contributions of antibiotic penetration, oxygen limitation, and low metabolic activity to tolerance of Pseudomonas aeruginosa biofilms to ciprofloxacin and tobramycin.
Topics: Biofilms; Ciprofloxacin; Pseudomonas aeruginosa; Tobramycin | 2003 |
Ciprofloxacin versus tobramycin for neutropenic fevers.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Drug Therapy, Combination; Fever; Humans; Neutropenia; Opportunistic Infections; Penicillins; Piperacillin; Tobramycin | 2003 |
Ciprofloxacin versus tobramycin for neutropenic fevers.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Drug Therapy, Combination; Fever; Humans; Neutropenia; Opportunistic Infections; Penicillins; Piperacillin; Tobramycin | 2003 |
Ecthyma gangrenosum arising from Pseudomonas aeruginosa dacryocystitis.
Topics: Aged; Anti-Infective Agents; Ciprofloxacin; Dacryocystitis; Dacryocystorhinostomy; Debridement; Drug Therapy, Combination; Ecthyma; Eye Infections, Bacterial; Eyelid Diseases; Female; Gangrene; Humans; Intubation; Pseudomonas Infections; Skin; Tobramycin; Tomography, X-Ray Computed | 2003 |
Survey of resistance of Pseudomonas aeruginosa from UK patients with cystic fibrosis to six commonly prescribed antimicrobial agents.
Topics: Adult; Anti-Bacterial Agents; Ceftazidime; Ciprofloxacin; Colistin; Cystic Fibrosis; Drug Resistance, Bacterial; Gentamicins; Humans; Piperacillin; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin | 2003 |
Antimicrobial spectrum of activity for meropenem and nine broad spectrum antimicrobials: report from the MYSTIC Program (2002) in North America.
Topics: Anti-Bacterial Agents; Aztreonam; Cefepime; Cephalosporins; Ciprofloxacin; Drug Resistance, Bacterial; Drug Resistance, Multiple; Female; Gentamicins; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Male; Meropenem; Microbial Sensitivity Tests; North America; Sensitivity and Specificity; Thienamycins; Tobramycin | 2003 |
Rapid direct method for monitoring antibiotics in a mouse model of bacterial biofilm infection.
Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; Biofilms; Catheterization; Ciprofloxacin; Colony Count, Microbial; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Monitoring; Luminescent Measurements; Mice; Rifampin; Staphylococcus aureus; Tobramycin | 2003 |
Evaluation of antibiotic-loaded collagen-hyaluronic acid matrix as a skin substitute.
Topics: Animals; Anti-Bacterial Agents; Biocompatible Materials; Biological Dressings; Cells, Cultured; Ciprofloxacin; Collagen; Drug Delivery Systems; Elasticity; Fibroblasts; Foreign-Body Reaction; Guinea Pigs; Humans; Hyaluronic Acid; Male; Materials Testing; Skin, Artificial; Tobramycin; Treatment Outcome; Wound Healing; Wounds, Penetrating | 2004 |
Effect of antibiotic sequence on combination regimens against Pseudomonas aeruginosa in a multiple-dose, in vitro infection model.
Topics: Ceftazidime; Ciprofloxacin; Culture Media, Conditioned; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Sensitivity and Specificity; Tobramycin | 2004 |
Surveillance of multi-drug resistant Pseudomonas aeruginosa in an urban tertiary-care teaching hospital.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactam Resistance; Ceftazidime; Ciprofloxacin; Colorado; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Hospitals, Teaching; Hospitals, Urban; Humans; Imipenem; Incidence; Intensive Care Units; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Sentinel Surveillance; Tobramycin | 2004 |
Effect of corticosteroid-antibiotic agents on granulation tissue in a murine model.
Topics: Administration, Topical; Adrenal Cortex Hormones; Animals; Anti-Bacterial Agents; Ciprofloxacin; Dexamethasone; Drug Combinations; Extracellular Matrix; Granulation Tissue; Hydrocortisone; Mice; Mice, Inbred C57BL; Tobramycin; Wound Healing | 2005 |
In vitro efficacy of the successive or staggered use of eardrops.
Topics: Acetic Acid; Adjuvants, Pharmaceutic; Administration, Topical; Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Dexamethasone; Drug Administration Schedule; Escherichia coli; Glucocorticoids; Humans; Microbial Sensitivity Tests; Ofloxacin; Otitis Media, Suppurative; Proteus mirabilis; Pseudomonas aeruginosa; Staphylococcus aureus; Tobramycin | 2006 |
Efficacy and potential for resistance selection of antipseudomonal treatments in a mouse model of lung infection by hypermutable Pseudomonas aeruginosa.
Topics: Animals; Anti-Bacterial Agents; Ciprofloxacin; Disease Models, Animal; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Female; Lung; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Mutation; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin | 2006 |
Pseudomonas keratitis after laser in situ keratomileusis.
Topics: Adult; Anti-Bacterial Agents; Cefazolin; Cephalosporin Resistance; Ciprofloxacin; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Humans; Kanamycin Resistance; Keratomileusis, Laser In Situ; Microbial Sensitivity Tests; Postoperative Complications; Pseudomonas Infections; Tobramycin | 2006 |
Interleukin-1, interleukin-6, and interleukin-10 responses after antibiotic treatment in experimental chronic Staphylococcus aureus osteomyelitis.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Cefuroxime; Chronic Disease; Ciprofloxacin; Disease Models, Animal; Interleukin-1; Interleukin-10; Interleukin-6; Interleukins; Male; Osteomyelitis; Rats; Rats, Wistar; Staphylococcal Infections; Tibia; Tobramycin; Vancomycin | 2006 |
Zymar (Gatifloxacin 0.3%) shows excellent Gram-negative activity against Serratia marcescens and Pseudomonas aeruginosa in a New Zealand White rabbit keratitis model.
Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Colony Count, Microbial; Corneal Ulcer; Disease Models, Animal; Eye Infections, Bacterial; Female; Fluoroquinolones; Gatifloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Serratia Infections; Serratia marcescens; Tobramycin | 2007 |
Antibiotics for local delivery systems cause skeletal cell toxicity in vitro.
Topics: 3T3 Cells; Animals; Anti-Bacterial Agents; Biocompatible Materials; Bone Cements; Cell Count; Cell Membrane; Cell Movement; Cell Survival; Chondrocytes; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Delivery Systems; L-Lactate Dehydrogenase; Mice; Osteoblasts; Tobramycin; Vancomycin | 2007 |
A comparison of topical chlorhexidine, ciprofloxacin, and fortified tobramycin/cefazolin in rabbit models of Staphylococcus and Pseudomonas keratitis.
Topics: Administration, Topical; Animals; Anti-Infective Agents, Local; Cefazolin; Chlorhexidine; Ciprofloxacin; Colony Count, Microbial; Cornea; Disease Models, Animal; Drug Combinations; Eye Infections, Bacterial; Keratitis; Microbial Sensitivity Tests; Ophthalmic Solutions; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Tobramycin | 2007 |
E. coli multiresistant meningitis after transrectal prostate biopsy.
Topics: Acute Disease; Aged; Ampicillin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Biopsy; Ciprofloxacin; Drug Resistance, Bacterial; Escherichia coli; Humans; Male; Meningitis; Prostate; Tobramycin | 2006 |
In vitro bactericidal activity of allicin combined with cefoperazone, tobramycin and ciprofloxacin.
Topics: Anti-Bacterial Agents; Blood Bactericidal Activity; Cefoperazone; Ciprofloxacin; Disulfides; Drug Combinations; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Sulfinic Acids; Tobramycin | 2008 |
Positive antibacterial co-action between hop (Humulus lupulus) constituents and selected antibiotics.
Topics: Anti-Infective Agents; Bacteria; Ciprofloxacin; Cyclohexenes; Drug Combinations; Drug Synergism; Flavonoids; Humulus; Microbial Sensitivity Tests; Plant Extracts; Polymyxin B; Propiophenones; Terpenes; Tobramycin | 2008 |
Involvement of a novel efflux system in biofilm-specific resistance to antibiotics.
Topics: Anti-Bacterial Agents; Biofilms; Biological Transport; Ciprofloxacin; Computational Biology; Drug Resistance, Multiple, Bacterial; Genes, Bacterial; Gentamicins; Microbial Sensitivity Tests; Mutation; Operon; Pseudomonas aeruginosa; Reverse Transcriptase Polymerase Chain Reaction; Tobramycin | 2008 |
Clinicobacteriological study of chronic dacryocystitis in adults.
Topics: Adult; Age Factors; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Chloramphenicol; Chronic Disease; Ciprofloxacin; Dacryocystitis; Female; Humans; Inflammation; Lacrimal Apparatus; Male; Middle Aged; Pilot Projects; Staphylococcal Infections; Tobramycin | 2008 |
Neutrophil enhancement of Pseudomonas aeruginosa biofilm development: human F-actin and DNA as targets for therapy.
Topics: Actins; Anti-Bacterial Agents; Biofilms; Ciprofloxacin; Deoxyribonucleases; DNA; Humans; Neutrophils; Peptides; Pseudomonas aeruginosa; Tobramycin | 2009 |
[Bacterial corneal ulcer treated with intrastromal antibiotic. Experimental model in vivo].
Topics: Analysis of Variance; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Cornea; Corneal Stroma; Corneal Ulcer; Data Interpretation, Statistical; Disease Models, Animal; Female; Gentamicins; Ofloxacin; Prospective Studies; Pseudomonas Infections; Rabbits; Tobramycin; Treatment Outcome | 2009 |
Implementation of European standards of care for cystic fibrosis--control and treatment of infection.
Topics: Administration, Inhalation; Adult; Anti-Bacterial Agents; Bacterial Infections; Burkholderia cepacia; Burkholderia Infections; Child; Child, Preschool; Ciprofloxacin; Colistin; Cystic Fibrosis; Europe; Guideline Adherence; Humans; Infection Control; Practice Guidelines as Topic; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections; Surveys and Questionnaires; Tobramycin; Young Adult | 2009 |
The costs of treatment of early and chronic Pseudomonas aeruginosa infection in cystic fibrosis patients.
Topics: Adult; Anti-Bacterial Agents; Ceftazidime; Child, Preschool; Chronic Disease; Ciprofloxacin; Clavulanic Acids; Colistin; Cost of Illness; Cystic Fibrosis; Humans; Meropenem; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Thienamycins; Ticarcillin; Tobramycin | 2009 |
Effects of iron depletion on antimicrobial activities against planktonic and biofilm Pseudomonas aeruginosa.
Topics: 2,2'-Dipyridyl; Anti-Infective Agents; Biofilms; Ceftazidime; Ciprofloxacin; Iron; Nutritive Value; Plankton; Pseudomonas aeruginosa; Tobramycin | 2009 |
Ecological effects of selective decontamination on resistant gram-negative bacterial colonization.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Ceftazidime; Ciprofloxacin; Cross Infection; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Intensive Care Units; Longitudinal Studies; Rectum; Respiratory System; Respiratory Tract Infections; Tobramycin | 2010 |
In-vitro efficacy of synergistic antibiotic combinations in multidrug resistant Pseudomonas aeruginosa strains.
Topics: Anti-Bacterial Agents; Ceftazidime; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Imipenem; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Pseudomonas aeruginosa; Tazobactam; Tobramycin | 2010 |
Topical levofloxacin 1.5% overcomes in vitro resistance in rabbit keratitis models.
Topics: Administration, Topical; Animals; Anti-Bacterial Agents; Cefazolin; Ciprofloxacin; Colony Count, Microbial; Corneal Stroma; Corneal Ulcer; Disease Models, Animal; Drug Resistance, Bacterial; Eye Infections, Bacterial; Levofloxacin; Ofloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Tobramycin; Vancomycin | 2010 |
Stationary biofilm growth normalizes mutation frequencies and mutant prevention concentrations in Pseudomonas aeruginosa from cystic fibrosis patients.
Topics: Anti-Bacterial Agents; Biofilms; Ceftazidime; Ciprofloxacin; Cystic Fibrosis; Drug Resistance, Bacterial; Genetic Variation; Humans; Imipenem; Microbial Sensitivity Tests; Mutation; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory System; Tobramycin | 2011 |
Impact of silver-containing wound dressings on bacterial biofilm viability and susceptibility to antibiotics during prolonged treatment.
Topics: Anti-Bacterial Agents; Bandages; Biofilms; Ciprofloxacin; Microbial Viability; Pseudomonas aeruginosa; Silver Compounds; Time Factors; Tobramycin; Trimethoprim, Sulfamethoxazole Drug Combination; Wound Infection | 2010 |
Antimicrobial resistance in more than 100,000 Escherichia coli isolates according to culture site and patient age, gender, and location.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Ampicillin; Anti-Bacterial Agents; Cefotaxime; Child; Child, Preschool; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Fosfomycin; Humans; Imipenem; Infant; Male; Middle Aged; Nitrofurantoin; Retrospective Studies; Tobramycin; Young Adult | 2011 |
Economic effects of an eradication protocol for first appearance of Pseudomonas aeruginosa in cystic fibrosis patients: 1995 vs. 2009.
Topics: Administration, Oral; Adolescent; Anti-Bacterial Agents; Anti-Infective Agents; Burkholderia cepacia complex; Child; Child, Preschool; Ciprofloxacin; Cohort Studies; Colistin; Cystic Fibrosis; Disease-Free Survival; Drug Administration Schedule; Drug Therapy, Combination; Health Care Costs; Health Resources; Humans; Infant; Injections, Intravenous; Nebulizers and Vaporizers; Piperacillin; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin; Treatment Outcome | 2011 |
[Ornithinimicrobium pekingense ocular infection].
Topics: Actinomycetales; Actinomycetales Infections; Aged; Cataract; Ciprofloxacin; Corneal Edema; Corneal Ulcer; Drug Resistance, Multiple, Bacterial; Female; Fusidic Acid; Humans; Keratoplasty, Penetrating; Ointments; Ophthalmic Solutions; Postoperative Complications; Rifamycins; Tobramycin | 2011 |
[Combined application of ciprofloxacin and tobramycin on mutant selective windows of ciprofloxacin against Pseudomonas aeruginosa].
Topics: Animals; Ciprofloxacin; Disease Models, Animal; Drug Resistance, Bacterial; Drug Therapy, Combination; Microbial Sensitivity Tests; Mutation; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Tobramycin | 2011 |
What have we learned about early treatment of Pseudomonas aeruginosa infection in infants and children with cystic fibrosis?
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Cystic Fibrosis; Female; Humans; Male; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin | 2011 |
Susceptibility of Pseudomonas aeruginosa urinary tract isolates and influence of urinary tract conditions on antibiotic tolerance.
Topics: Anti-Bacterial Agents; Biofilms; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Humans; Iron; Microbial Sensitivity Tests; Oxygen; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin; Urinary Tract; Urinary Tract Infections | 2012 |
[In vitro combination effects of doripenem with aminoglycoside or ciprofloxacin against Pseudomonas aeruginosa].
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Carbapenems; Ciprofloxacin; Doripenem; Drug Combinations; Drug Resistance, Bacterial; Drug Synergism; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Tobramycin | 2011 |
In vitro evaluation of novel compounds against selected resistant Pseudomonas aeruginosa isolates.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Cytosine; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pyrroles; Ribosome Subunits, Large, Bacterial; Tobramycin | 2012 |
In vitro activities of the novel ceragenin CSA-13, alone or in combination with colistin, tobramycin, and ciprofloxacin, against Pseudomonas aeruginosa strains isolated from cystic fibrosis patients.
Topics: Ciprofloxacin; Colistin; Cystic Fibrosis; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Steroids; Tobramycin | 2011 |
Heterogeneity in Pseudomonas aeruginosa biofilms includes expression of ribosome hibernation factors in the antibiotic-tolerant subpopulation and hypoxia-induced stress response in the metabolically active population.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Biofilms; Ciprofloxacin; Drug Resistance, Bacterial; Gene Expression Regulation, Bacterial; Oxygen; Pseudomonas aeruginosa; Stress, Physiological; Tobramycin | 2012 |
Reverting antibiotic tolerance of Pseudomonas aeruginosa PAO1 persister cells by (Z)-4-bromo-5-(bromomethylene)-3-methylfuran-2(5H)-one.
Topics: 4-Butyrolactone; Analysis of Variance; Anti-Bacterial Agents; Biofilms; Carbenicillin; Ciprofloxacin; Drug Resistance, Bacterial; Drug Synergism; Genes, Bacterial; Gentamicins; Microbial Sensitivity Tests; Oligonucleotide Array Sequence Analysis; Pseudomonas aeruginosa; Quorum Sensing; Tetracycline; Tobramycin; Transcriptome | 2012 |
Interplay between population dynamics and drug tolerance of Staphylococcus aureus persister cells.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Colony Count, Microbial; Daptomycin; Drug Tolerance; Microbial Viability; Models, Theoretical; Population Dynamics; Staphylococcus aureus; Tobramycin | 2012 |
Effects of azithromycin in Pseudomonas aeruginosa burn wound infection.
Topics: Animals; Anti-Bacterial Agents; Azithromycin; Burns; Ciprofloxacin; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Female; Male; Mice; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin; Treatment Outcome; Wound Infection | 2013 |
The extracellular matrix protects Pseudomonas aeruginosa biofilms by limiting the penetration of tobramycin.
Topics: Anti-Infective Agents; Biofilms; Ciprofloxacin; Extracellular Matrix; Pseudomonas aeruginosa; Tobramycin | 2013 |
Rapid detection of antibiotic resistance based on mass spectrometry and stable isotopes.
Topics: Amino Acids; Anti-Bacterial Agents; Ciprofloxacin; Culture Media; Drug Resistance, Bacterial; Isotope Labeling; Isotopes; Mass Spectrometry; Meropenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Thienamycins; Time Factors; Tobramycin | 2014 |
Treatment failure due to induction of ciprofloxacin resistance during combination therapy with colistin and ciprofloxacin in multidrug-resistant Pseudomonas aeruginosa bacteraemia.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Cefepime; Cephalosporins; Ciprofloxacin; Colistin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Immunocompromised Host; Meropenem; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins; Tobramycin; Treatment Failure | 2014 |
Differential roles of RND efflux pumps in antimicrobial drug resistance of sessile and planktonic Burkholderia cenocepacia cells.
Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Base Sequence; Biofilms; Burkholderia cenocepacia; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Gene Expression Regulation, Bacterial; Genes, MDR; Membrane Transport Proteins; Microbial Sensitivity Tests; Molecular Sequence Data; Operon; Plankton; RNA, Messenger; Sequence Deletion; Tobramycin | 2014 |
Activities of antibiotic combinations against resistant strains of Pseudomonas aeruginosa in a model of infected THP-1 monocytes.
Topics: Anti-Bacterial Agents; Cell Line; Ciprofloxacin; Colistin; Drug Resistance, Bacterial; Drug Synergism; Drug Therapy, Combination; Humans; Meropenem; Microbial Sensitivity Tests; Monocytes; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins; Tobramycin | 2015 |
Contribution of stress responses to antibiotic tolerance in Pseudomonas aeruginosa biofilms.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Biofilms; Biological Transport; Cell Hypoxia; Ciprofloxacin; Drug Resistance, Bacterial; Gene Expression Regulation, Bacterial; Ligases; Osmotic Pressure; Pseudomonas aeruginosa; Pyrophosphatases; Quorum Sensing; Sigma Factor; SOS Response, Genetics; Stress, Physiological; Tobramycin | 2015 |
Mucin Binding Reduces Colistin Antimicrobial Activity.
Topics: Acinetobacter baumannii; Animals; Anti-Bacterial Agents; Ciprofloxacin; Colistin; Culture Media; Daptomycin; Dialysis; Dialysis Solutions; Escherichia coli; Klebsiella pneumoniae; Microbial Sensitivity Tests; Mucins; Polymyxin B; Protein Binding; Pseudomonas aeruginosa; Staphylococcus aureus; Swine; Tobramycin | 2015 |
Silver- and fluoride-containing mesoporous bioactive glasses versus commonly used antibiotics: Activity against multidrug-resistant bacterial strains isolated from patients with burns.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Aztreonam; Burns; Carbenicillin; Cefepime; Ceftazidime; Ceftriaxone; Cell Survival; Cephalosporins; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Fluorides; Gentamicins; Glass; Humans; Imipenem; Meropenem; Mice; Microbial Sensitivity Tests; NIH 3T3 Cells; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Silver; Thienamycins; Tobramycin; Wound Infection | 2016 |
Impairment of Pseudomonas aeruginosa Biofilm Resistance to Antibiotics by Combining the Drugs with a New Quorum-Sensing Inhibitor.
Topics: Amides; Anti-Bacterial Agents; Bacterial Adhesion; Biofilms; Ciprofloxacin; Colistin; Cystic Fibrosis; Drug Synergism; Drug Therapy, Combination; Humans; Lung; Microscopy, Confocal; Pseudomonas aeruginosa; Pseudomonas Infections; Pyrimidines; Quorum Sensing; Respiratory Tract Infections; Tobramycin | 2015 |
MBT-ASTRA: A suitable tool for fast antibiotic susceptibility testing?
Topics: Anti-Bacterial Agents; Bacteria; Cefotaxime; Ciprofloxacin; Drug Resistance, Microbial; Humans; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Tobramycin | 2016 |
Clinically relevant concentrations of fosfomycin combined with polymyxin B, tobramycin or ciprofloxacin enhance bacterial killing of Pseudomonas aeruginosa, but do not suppress the emergence of fosfomycin resistance.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Interactions; Drug Resistance, Bacterial; Fosfomycin; Humans; Microbial Viability; Polymyxin B; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin | 2016 |
Dynamics of Mutations during Development of Resistance by Pseudomonas aeruginosa against Five Antibiotics.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Ceftazidime; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Microbial; Meropenem; Microbial Sensitivity Tests; Mutation; Piperacillin; Pseudomonas aeruginosa; Thienamycins; Tobramycin | 2016 |
An Immunocompromised Child with Bloodstream Infection Caused by Two Escherichia coli Strains, One Harboring NDM-5 and the Other Harboring OXA-48-Like Carbapenemase.
Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Aztreonam; Bacterial Proteins; beta-Lactamases; beta-Lactams; Ciprofloxacin; Ertapenem; Escherichia coli; Female; Gentamicins; Humans; Immunocompromised Host; Meropenem; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Tazobactam; Thienamycins; Tobramycin | 2016 |
The Role of Reactive Oxygen Species in Antibiotic-Induced Cell Death in Burkholderia cepacia Complex Bacteria.
Topics: Anti-Bacterial Agents; Biofilms; Burkholderia cepacia complex; Burkholderia Infections; Cell Death; Ciprofloxacin; Gene Expression Regulation, Bacterial; Meropenem; Microbial Sensitivity Tests; Reactive Oxygen Species; Repressor Proteins; Thienamycins; Tobramycin | 2016 |
Difference of Type 3 secretion system (T3SS) effector gene genotypes (exoU and exoS) and its implication to antibiotics resistances in isolates of Pseudomonas aeruginosa from chronic otitis media.
Topics: ADP Ribose Transferases; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Chaperonin 60; Chronic Disease; Ciprofloxacin; Drug Resistance, Bacterial; Female; Genotype; Glucosyltransferases; GTPase-Activating Proteins; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Otitis Media; Pseudomonas aeruginosa; Pseudomonas Infections; Reverse Transcriptase Polymerase Chain Reaction; Tobramycin; Type III Secretion Systems; Virulence Factors | 2017 |
Reducing Second Gram-Negative Antibiotic Therapy on Pediatric Oncology and Hematopoietic Stem Cell Transplantation Services.
Topics: Adolescent; Anti-Bacterial Agents; Antimicrobial Stewardship; beta-Lactams; Child; Child, Preschool; Ciprofloxacin; Drug Combinations; Drug Utilization; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Guidelines as Topic; Hematopoietic Stem Cell Transplantation; Hospitals, Pediatric; Humans; Length of Stay; Medical Oncology; Neutropenia; Pediatrics; Poisson Distribution; San Francisco; Tobramycin; Treatment Outcome | 2017 |
Identification and antimicrobial susceptibility of clinical Nocardia species in a tertiary hospital in China.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; China; Ciprofloxacin; Clarithromycin; Drug Resistance, Bacterial; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Nocardia; Nocardia Infections; Population Surveillance; Tertiary Care Centers; Tobramycin; Young Adult | 2017 |
Topics: Anti-Bacterial Agents; Cefepime; Ceftazidime; Cephalosporins; Ciprofloxacin; Drug Combinations; Drug Resistance, Multiple, Bacterial; Febrile Neutropenia; Humans; Iatrogenic Disease; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia; Practice Guidelines as Topic; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis; Tazobactam; Thienamycins; Tobramycin | 2017 |
Synergistic effects of heat and antibiotics on Pseudomonas aeruginosa biofilms.
Topics: Anti-Bacterial Agents; Biofilms; Ciprofloxacin; Drug Resistance, Bacterial; Erythromycin; Heat-Shock Response; Hot Temperature; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Tobramycin | 2017 |
Clinical Features, Antibiotic Susceptibility Profile, and Outcomes of Infectious Keratitis Caused by Stenotrophomonas maltophilia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Ciprofloxacin; Corneal Ulcer; Eye Infections, Bacterial; Female; Gram-Negative Bacterial Infections; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Polymyxin B; Retrospective Studies; Risk Factors; Stenotrophomonas maltophilia; Tobramycin; Trimethoprim, Sulfamethoxazole Drug Combination; Young Adult | 2018 |
Screening, cloning and expression of a novel alginate lyase gene from P. aeruginosa TAG 48 and its antibiofilm effects on P. aeruginosa biofilm.
Topics: Alginates; Anti-Bacterial Agents; Bacterial Proteins; Ciprofloxacin; Cloning, Molecular; Humans; Microbial Sensitivity Tests; Polysaccharide-Lyases; Pseudomonas aeruginosa; Pseudomonas Infections; Substrate Specificity; Tobramycin; Virulence Factors | 2018 |
Synergy of nebulized phage PEV20 and ciprofloxacin combination against Pseudomonas aeruginosa.
Topics: Amikacin; Anti-Bacterial Agents; Aztreonam; Ciprofloxacin; Colistin; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Phages; Tobramycin | 2018 |
Antibiotic resistance among bacterial conjunctival pathogens collected in the Antibiotic Resistance Monitoring in Ocular Microorganisms (ARMOR) surveillance study.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Anti-Bacterial Agents; Azithromycin; Child; Child, Preschool; Ciprofloxacin; Conjunctiva; Conjunctivitis, Bacterial; Drug Resistance, Multiple, Bacterial; Epidemiological Monitoring; Female; Haemophilus influenzae; Humans; Infant; Infant, Newborn; Male; Methicillin; Microbial Sensitivity Tests; Middle Aged; Oxacillin; Pseudomonas aeruginosa; Staphylococcus aureus; Streptococcus pneumoniae; Tobramycin; Trimethoprim; United States | 2018 |
No benefit of longer eradication therapy of Pseudomonas aeruginosa primoinfections in pediatric cystic fibrosis.
Topics: Anti-Bacterial Agents; Child; Ciprofloxacin; Clinical Protocols; Cystic Fibrosis; Female; Humans; Male; Outcome and Process Assessment, Health Care; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Time Factors; Tobramycin | 2019 |
Topics: Anti-Bacterial Agents; Bronchoalveolar Lavage; Ceftazidime; Child, Preschool; Ciprofloxacin; Clavulanic Acids; Cross-Sectional Studies; Cystic Fibrosis; Female; Humans; Infant; Longitudinal Studies; Male; Prevalence; Pseudomonas aeruginosa; Pseudomonas Infections; Pulmonary Aspergillosis; Randomized Controlled Trials as Topic; Recurrence; Risk Factors; Ticarcillin; Tobramycin | 2019 |
In vitro evaluation of Pseudomonas aeruginosa chronic lung infection models: Are agar and calcium-alginate beads interchangeable?
Topics: Agar; Alginates; Animals; Anti-Bacterial Agents; Ciprofloxacin; Disease Models, Animal; Lung; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections; Tobramycin | 2019 |
Genomic and phenotypic comparison of environmental and patient-derived isolates of
Topics: Anti-Bacterial Agents; Ceftazidime; Ciprofloxacin; Cystic Fibrosis; Drug Resistance, Bacterial; Environmental Microbiology; Genomics; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin | 2019 |
Spray-drying of inhalable, multifunctional formulations for the treatment of biofilms formed in cystic fibrosis.
Topics: Acetylcysteine; Administration, Inhalation; Animals; Anti-Bacterial Agents; Azithromycin; Biofilms; Ciprofloxacin; Cystic Fibrosis; Drug Stability; Drug Storage; Expectorants; Horses; Mucus; Particle Size; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin | 2019 |
Multidrug Adaptive Resistance of Pseudomonas aeruginosa Swarming Cells.
Topics: Aminoglycosides; Chloramphenicol; Ciprofloxacin; Drug Resistance, Microbial; Gene Expression Regulation, Bacterial; Macrolides; Mutation; Pseudomonas aeruginosa; Reverse Transcriptase Polymerase Chain Reaction; RNA-Seq; Tetracycline; Tobramycin; Trimethoprim | 2020 |
In Vitro Activity of Fosfomycin in Double and Triple Combinations with Imipenem, Ciprofloxacin and Tobramycin Against Multidrug-Resistant Escherichia coli.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Egypt; Fosfomycin; Imipenem; Microbial Sensitivity Tests; Tobramycin; Uropathogenic Escherichia coli | 2020 |
Disruption of the extracellular polymeric network of Pseudomonas aeruginosa biofilms by alginate lyase enhances pathogen eradication by antibiotics.
Topics: Biofilms; Ciprofloxacin; Cystic Fibrosis; Drug Synergism; Polysaccharide-Lyases; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin | 2021 |
PVA/anionic collagen membranes as drug carriers of ciprofloxacin hydrochloride with sustained antibacterial activity and potential use in the treatment of ulcerative keratitis.
Topics: Anti-Bacterial Agents; Biocompatible Materials; Ciprofloxacin; Collagen; Contact Lenses; Cornea; Corneal Ulcer; Drug Carriers; Drug Compounding; Escherichia coli; Humans; Mechanical Phenomena; Ophthalmic Solutions; Permeability; Polyvinyl Alcohol; Staphylococcus aureus; Surface Properties; Tobramycin; Water; Wettability | 2020 |
Combining antibiotics with antivirulence compounds can have synergistic effects and reverse selection for antibiotic resistance in Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Ciprofloxacin; Colistin; Drug Combinations; Drug Resistance, Multiple, Bacterial; Drug Synergism; Furans; Gallium; Humans; Meropenem; Microbial Sensitivity Tests; Protein Biosynthesis; Pseudomonas aeruginosa; Quorum Sensing; Tobramycin; Virulence | 2020 |
Molecular Detection of
Topics: Agar; Anti-Bacterial Agents; Anti-Infective Agents; Cefazolin; Cefepime; Ciprofloxacin; DNA Gyrase; Drug Resistance, Bacterial; Genotype; Humans; Inhibitory Concentration 50; Iraq; Microbial Sensitivity Tests; Nalidixic Acid; Polymerase Chain Reaction; Salmonella typhi; Tobramycin; Typhoid Fever | 2020 |
Spray-dried multidrug particles for pulmonary co-delivery of antibiotics with N-acetylcysteine and curcumin-loaded PLGA-nanoparticles.
Topics: Acetylcysteine; Administration, Inhalation; Anti-Bacterial Agents; Anti-Inflammatory Agents; Azithromycin; Ciprofloxacin; Curcumin; Cytokines; Drug Carriers; Drug Combinations; Drug Compounding; Expectorants; Freeze Drying; Humans; Inflammation Mediators; Macrophages; Microbial Viability; Mucus; Nanoparticles; Permeability; Polylactic Acid-Polyglycolic Acid Copolymer; Pseudomonas aeruginosa; Pseudomonas Infections; THP-1 Cells; Tobramycin | 2020 |
Contribution of Drugs Interfering with Protein and Cell Wall Synthesis to the Persistence of
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Bacterial Proteins; Biofilms; Ceftazidime; Cell Wall; Ciprofloxacin; Cyclic GMP; Drug Combinations; Drug Resistance, Multiple, Bacterial; Gene Expression Regulation, Bacterial; Green Fluorescent Proteins; In Vitro Techniques; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Tobramycin; Transformation, Bacterial | 2021 |
Insights into collateral susceptibility and collateral resistance in Acinetobacter baumannii during antimicrobial adaptation.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adaptation, Biological; Anti-Bacterial Agents; beta-Lactamases; Ciprofloxacin; Drug Collateral Sensitivity; Drug Resistance, Multiple, Bacterial; Humans; Meropenem; Microbial Sensitivity Tests; Polymyxin B; Tetracycline; Tobramycin | 2021 |
Synergistic bactericidal activities of tobramycin with ciprofloxacin and azithromycin against Klebsiella pneumoniae.
Topics: Animals; Anti-Bacterial Agents; Azithromycin; Biofilms; Ciprofloxacin; Codon; Dogs; Drug Resistance, Microbial; Drug Synergism; Humans; Klebsiella Infections; Klebsiella pneumoniae; Luminescent Proteins; Microbial Sensitivity Tests; Red Fluorescent Protein; Tobramycin | 2021 |
Distinct contribution of hyperbaric oxygen therapy to human neutrophil function and antibiotic efficacy against Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Combined Modality Therapy; Humans; Hyperbaric Oxygenation; Hyperoxia; In Vitro Techniques; Microbial Sensitivity Tests; Neutrophils; Penicillins; Reactive Oxygen Species; Staphylococcal Infections; Staphylococcus aureus; Tobramycin | 2021 |
Vitek
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Ciprofloxacin; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Tobramycin | 2021 |
Silver nanoparticles as a bioadjuvant of antibiotics against biofilm-mediated infections with methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa in chronic rhinosinusitis patients.
Topics: Anti-Bacterial Agents; Biofilms; Ciprofloxacin; Clindamycin; Doxycycline; Gentamicins; Humans; Metal Nanoparticles; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Silver; Staphylococcus aureus; Tobramycin | 2022 |
Effectiveness of different eradication treatment protocols for new-onset Pseudomonas aeruginosa in children with cystic fibrosis.
Topics: Administration, Inhalation; Anti-Bacterial Agents; Child; Ciprofloxacin; Clinical Protocols; Cystic Fibrosis; Humans; Observational Studies as Topic; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Tobramycin | 2022 |
Introducing the Escalation Antibiogram: A Simple Tool to Inform Changes in Empiric Antimicrobials in the Nonresponding Patient.
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Bacteremia; Ceftriaxone; Ciprofloxacin; Ertapenem; Gentamicins; Gram-Negative Bacteria; Humans; Meropenem; Microbial Sensitivity Tests; Piperacillin, Tazobactam Drug Combination; Tobramycin; Trimethoprim, Sulfamethoxazole Drug Combination | 2022 |
Antimicrobial resistance, virulence factors, and genotypes of Pseudomonas aeruginosa clinical isolates from Gorgan, northern Iran.
Topics: Amikacin; Anti-Bacterial Agents; Ceftazidime; Ciprofloxacin; Colistin; Deoxyribonucleases; Drug Resistance, Bacterial; Genotype; Gentamicins; Humans; Imipenem; Iran; Levofloxacin; Meropenem; Microbial Sensitivity Tests; Pancreatic Elastase; Phospholipases; Piperacillin; Piperacillin, Tazobactam Drug Combination; Polymyxin B; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin; Virulence Factors | 2022 |
Time kill-assays of antibiotic combinations for multidrug resistant clinical isolates of OXA-48 carbapenemase producing Klebsiella pneumoniae.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Ciprofloxacin; Colistin; Drug Synergism; Humans; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Tobramycin | 2022 |
Screening of Antibacterial Efficacy of Chitosan Encapsulated Probiotics (Lactococcus lactis and Lactobacillus curvattus) against Clinical Bacterial Pathogens.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Buffaloes; Ceftriaxone; Cephalothin; Cephradine; Chitosan; Chloramphenicol; Ciprofloxacin; Erythromycin; Lactobacillus; Lactococcus lactis; Probiotics; Tetracyclines; Tobramycin | 2022 |
Meropenem-loaded Cement Is Effective in Preventing Gram-negative Osteomyelitis in an Animal Model.
Topics: Animals; Anti-Bacterial Agents; Aztreonam; Bone Cements; Ceftazidime; Ciprofloxacin; Escherichia coli; Male; Meropenem; Microbial Sensitivity Tests; Models, Animal; Osteomyelitis; Piperacillin; Rats; Tobramycin | 2023 |
Appropriateness of Antibiotic Prescribing for Acute Conjunctivitis: A Cross-Sectional Study at a Specialist Eye Hospital in Ghana, 2021.
Topics: Acute Disease; Adolescent; Adult; Anti-Bacterial Agents; Child; Ciprofloxacin; Conjunctivitis; Cross-Sectional Studies; Female; Gentamicins; Ghana; Hospitals, Special; Humans; Male; Ointments; Practice Patterns, Physicians'; Tetracyclines; Tobramycin | 2022 |
Impact of N-Acetylcysteine and Antibiotics Against Single and Dual Species Biofilms of Pseudomonas aeruginosa and Achromobacter xylosoxidans.
Topics: Acetylcysteine; Achromobacter denitrificans; Animals; Anti-Bacterial Agents; Aztreonam; Biofilms; Caenorhabditis elegans; Ciprofloxacin; Cystic Fibrosis; Humans; Pseudomonas aeruginosa; Tobramycin | 2022 |
The Effects of Antibiotic Combination Treatments on Pseudomonas aeruginosa Tolerance Evolution and Coexistence with Stenotrophomonas maltophilia.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Colistin; Cystic Fibrosis; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Stenotrophomonas maltophilia; Tobramycin | 2022 |
Impact of fluoroquinolones and aminoglycosides on P. aeruginosa virulence factor production and cytotoxicity.
Topics: ADP Ribose Transferases; Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Proteins; Ciprofloxacin; Fluoroquinolones; Genotype; Humans; Moxifloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin; Virulence Factors | 2022 |
Rapid Phenotypic Convergence towards Collateral Sensitivity in Clinical Isolates of Pseudomonas aeruginosa Presenting Different Genomic Backgrounds.
Topics: Anti-Bacterial Agents; Aztreonam; Ciprofloxacin; Drug Collateral Sensitivity; Genomics; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin | 2023 |
Genotypic resistance determined by whole genome sequencing versus phenotypic resistance in 234 Escherichia coli isolates.
Topics: Amikacin; Amoxicillin; Anti-Bacterial Agents; Cefepime; Cefotaxime; Ceftazidime; Ciprofloxacin; Clavulanic Acid; Escherichia coli; Escherichia coli Infections; Genotype; Gentamicins; Humans; Meropenem; Microbial Sensitivity Tests; Phenotype; Piperacillin; Retrospective Studies; Tazobactam; Tobramycin; Whole Genome Sequencing | 2023 |
Ciprofloxacin resistance and tolerance of Pseudomonas aeruginosa ocular isolates.
Topics: Agar; Anti-Bacterial Agents; Ceftazidime; Ciprofloxacin; Gentamicins; Humans; Imipenem; Keratitis; Levofloxacin; Microbial Sensitivity Tests; Piperacillin; Polymyxin B; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin | 2023 |
Tackling antibiotic resistance by inducing transient and robust collateral sensitivity.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Ciprofloxacin; Dequalinium; Drug Collateral Sensitivity; Drug Resistance, Microbial; Membrane Transport Proteins; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Tobramycin; Transcription Factors | 2023 |
[Evaluation of Antimicrobial Susceptibilities of Rapidly Growing Mycobacteria].
Topics: Amikacin; Anti-Bacterial Agents; Cefoxitin; Ciprofloxacin; Clarithromycin; Doxycycline; Humans; Imipenem; Linezolid; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Tobramycin | 2023 |
Genomics of Aminoglycoside Resistance in Pseudomonas aeruginosa Bloodstream Infections at a United States Academic Hospital.
Topics: Aminoglycosides; Anti-Bacterial Agents; Ciprofloxacin; Colistin; Drug Resistance, Bacterial; Genomics; Gentamicins; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis; Tobramycin; United States | 2023 |
Determining effects of nitrate, arginine, and ferrous on antibiotic recalcitrance of clinical strains of Pseudomonas aeruginosa in biofilm-inspired alginate encapsulates.
Topics: Alginates; Amikacin; Anti-Bacterial Agents; Arginine; Biofilms; Ciprofloxacin; Cystic Fibrosis; Humans; Microbial Sensitivity Tests; Nitrates; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin | 2023 |
Remarkable antibiofilm activity of ciprofloxacin, cefoxitin, and tobramycin, by themselves or in combination, against enteroaggregative Escherichia coli in vitro.
Topics: Ampicillin; Anti-Bacterial Agents; Biofilms; Cefoxitin; Ciprofloxacin; Diarrhea; Escherichia coli; Escherichia coli Infections; Humans; Tobramycin | 2023 |
Biofilm formation on endovascular aneurysm repair (EVAR) grafts-a proof of concept in vitro model.
Topics: Anti-Bacterial Agents; Aortic Aneurysm, Abdominal; Bacteria; Biofilms; Blood Vessel Prosthesis Implantation; Ciprofloxacin; Endovascular Aneurysm Repair; Endovascular Procedures; Humans; Penicillin G; Staphylococcus aureus; Tobramycin | 2023 |